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LIST OF ABBREVATIONS
AG Adenomatous goiter
ATC Anaplastic thyroid carcinoma
ECG Electrocardiogram
FNAC Fine needle aspiration cytology
HPE Histopathological examination
MIT Monoiodotyrosine
MNG Multinodular goiter
MTC Medullary thyroid carcinoma
RLN Recurrent laryngeal nerve
SNT Solitary nodule thyroid
T3 Tri-iodotyrosine
T4 Thyroxine
TBG Thyroxine binding globulin
TR Thyroid hormone receptor
USG Ultrasonography
ABSTRACT
Background
Solitary nodule of thyroid has increased in incidence in the present day as compared
to two decades before. Because of possibility of malignancy, some clinicians especially those
in surgical subspecialities recommended that all nodules have to be removed.
Objectives of the Study
1. To determine the incidence of malignancy in solitary nodule of thyroid in
general population and in relation to age and sex.
2. To determine the incidence of solitary nodule of thyroid turning out to be
multi-nodular goiter. To study the incidences of euthyroid, hyperthyroid or
hypothyroid states in patients presenting with solitary nodule of thyroid.
3. To study the role of FNAC in the management of solitary nodule of thyroid.
4. To determine the incidence of adenoma, carcinoma and thyroiditis as a cause
of solitary nodule of thyroid in T.V.M.C, Thirunelveli.
MATERIALS AND METHODS
Source of Data
Patients with Solitary nodule thyroid admitted to various surgical wards in T.V.M.C,
Thirunelveli during the period of September 2014 — August 2015.
Method of Collecting Data
Data collection by meticulous history taking and clinical examination,
appropriate laboratory and radiological investigations, operative findings,
histopathological report and follow up of cases.
The study of minimum 50 cases selected by Random Sampling Technique admitted tc
surgical wards of T.V.M.C, Thirunelveli during the period of September 2014 -August 2015.
Inclusion Criteria
Patients admitted to surgical wards of T.V.M.C, Thirunelveli with features of SNT.
Exclusion Criteria
 Patients with diffuse enlargement of thyroid.
 Patients presenting with MNG clinically*.
 Patients refusing for investigations / management.
Results:
Commonest presentation of solitary thyroid nodule was asymptomatic. The Peak
incidence of solitary nodule was observed in 3rd to 5th decade, constituting 60% of the cases
studied. Females predominated in number over males in occurrence of solitary nodule in ratio
of 1:11.5.  36% of all clinically solitary nodule turned out to  be multi-nodular goiter.  The
common causes  of  solitary  nodule  was MNG (36%), follicular adenoma (22%),
adenomatous goiter (24%). 94% 0f cases presented with euthyroid state. Incidence of
malignancy in solitary thyroid nodule was 12%. Male to female ratio in case of malignant
nodule was1:5. Incidence of  carcinoma  in  males  presenting  as  solitary  nodule  was
higher (25%) compared to that of females (10.87%). The  most common cause of malignancy
was papillary carcinoma (67%) followed by follicular carcinoma (33%). .
Interpretation and Conclusion:
Solitary nodule of thyroid is more common in 3rd to 5th decades. Solitary nodule of
thyroid are more common in females. Most of the patients presenting with solitary nodule of
thyroid are euthyroid  and only a small percentage of patient with  toxicity or hypothyroidism
USG can  be accurately used  to detect patients with multinodulary goiter who clinically
present as solitary nodule of thyroid. Common causes of solitary nodule of thyroid are MNG,
follicular adenoma and adenomatous goiter. Incidence of malignancy in male patients
presenting with solitary nodule of thyroid is more when compared to female. The most
common cause of malignancy in solitary nodule is papillary carcinoma followed by follicular
carcinoma.
Key words : solitary nodule, malignancy, euthyroid.
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1INTRODUCTION
The solitary thyroid nodule has aroused interest of thyroidologist since the time of
Warren H Cole (1949) and his study concluded that incidence of malignancy is higher when
compared with multinodular goitre.
Thyroid nodules are very common entities, though varying in incidence in different
geographical regions. the prevalence of palpable nodules in general population is 4-7%.
Solitary nodules of thyroid are about four times more common in women than in men.
Overall incidence of malignancy in solitary thyroid nodule ranges from 10-30%.
Definition:
A single nodule in the thyroid is a definite clinical entity with important pathological
significance. It is necessary to consider the status of opposite lobe when considering the
‘solitariness’ of the nodule. Ignoring palpability of opposite lobe is likely to lead to a higher
incidence of solitary nodule turning out to be multi-nodular goiter.
Another factor that influences the ultimate histopathological outcome of solitary
nodule of solitary nodule thyroid is whether the definition of solitariness is entirely clinical or
proved by investigations like U/S, radio iodine scan etc. in general a solitary nodule is
defined as “a palpable single clinically detected nodule in the thyroid gland that is otherwise
normal.” Visibility or palpability of opposite thyroid lobe precludes inclusion of such cases in
this group.
The usual presentation of a thyroid nodule is an asymptomatic mass that is discovered by
either the patient or the clinician. Nodules of at least 0.5cm to 1cm can be usually be detected by
palpation, although estimates of nodule size varies from physician to physician. It can be difficult
to palpate any nodule in patient with a thick, short neck .
2The thyroid nodule has been subject of vigorous controversy with divergent opinions
expressed by those who had wide experience in this field. The optimal management of
thyroid nodule continues to be a source of controversy and the operative intervention
recommended by most of surgeons is not always considered divine by some physicians
advocating either observation or suppression .
The importance of discrete swelling lies in the risk of neoplasia compared with other
thyroid swellings. Some 15% of isolated swelling prove to be malignant and non-neoplastic,
largely consisting of malignancy or follicular adenoma in clinically dominant swelling is
approximately half that of truly isolated swelling ,it is substantial and cannot be ignored .
Because of possibility of malignancy, some clinicians especially those in surgical
subspecialties recommend that all nodules have to be removed. On the other hand
endocrinologist recommends FNAC performed as initial step of evaluation in order to avoid
unnecessary surgery.
AIMS AND OBJECTIVES
1. To determine the incidence of solitary nodule thyroid in relation to age and sex
2. To determine the incidence of solitary nodule of thyroid turning out to be
malignancy
3. To determine the incidence of solitary nodule of thyroid turning out to be multi
nodular goiter
4. To study the incidences of euthyroid, hyperthyroid or hypothyroid states in
patients presenting with solitary nodule of thyroid.
5. To study the role of FNAC in the management of solitary nodule of thyroid.
6. To determine the incidence of adenoma, carcinoma and thyroiditis as a cause of
solitary nodule of thyroid in  Thirunelveli medical college .
3REVIEW OF LITERATURE
Historical review
Goiters (from the Latin guttur, throat), defined as an enlargement of the thyroid, have
been recognized since 2700 B.C. The term thyroid gland (Greek thyreoeides, shield-shaped)
is, however, attributed to Thomas Wharton. In 1776, the thyroid was classified as a ductless
gland by Albrechtvon Haller and was thought to have numerous functions ranging from
lubrication of the larynx to acting as a reservoir for blood to provide continuous flow to the
brain, to beautifying women's necks. Burnt seaweed was considered to be the most effective
treatment for goiters.
The first accounts of thyroid surgery for the treatment of goiters were given by Roger
Frugardi in 1170. In response to failure of medical treatment, two setons were inserted at
right angles into the goiter and tightened twice daily until the goiter separated. The open
wound was treated with caustic powder and left to heal. However, thyroid surgery continued
to be hazardous with prohibitive mortality rates (>40%) until the latter half of the nineteenth
century, when advances in general anesthesia, antisepsis, and hemostasis enabled surgeons to
perform thyroid surgery with significantly reduced mortality and morbidity rates. The most
notable thyroid surgeons were Emil Theodor Kocher (1841– 1917) and C.A. Theodor Billroth
(1829–1894), who performed thousands of operations with increasingly successful results.
However, as more patients survived thyroid operations, new problems and issues became
apparent. After total thyroidectomy, patients (particularly children) became myxedematous
with cretinous features. Myxedema was first effectively treated in 1891 by George Murray
using a subcutaneous injection of an extract of sheep's thyroid and later, Edward Fox
demonstrated that oral therapy was equally effective. In 1909, Kocher was awarded the Nobel
Prize for medicine in recognition "for his works on the physiology, pathology, and surgery of
the thyroid gland."
4Theoder Kocher, Father of thyroid surgery
Kocher Billroth
5EMBRYOLOGY
Normal Development
The thyroid gland appears by the end of the third week as an epithelial thickening of
the floor of the pharynx at the level of the first pharyngeal pouch. This, the large median
thyroid anlage, may be a diverticulum or a solid bud. Cranial growth of the tongue, together
with elongation of the embryo, carries the origin of the thyroid gland far cranial to the gland
itself. The site of this origin is the foramen cecum of the adult tongue. In some individuals it
is not grossly visible.
The thyroid gland remains connected with the foramen cecum by a minute, solid
thyroglossal duct that passes through, or anterior to, the hyoid bone. By the fifth week of
gestation, this duct usually becomes fragmented; persistence of any portion is not unusual. In
about 50 percent of the population, the duct can be traced distally to the pyramidal lobe of the
thyroid gland .
The developing gland, at first an irregular plate, develops two lateral wings connected
by the isthmus. Follicles appear during the second month of gestation and increase through
the fourth month. Colloid formation and uptake of radioactive iodine begin at about the
eleventh week.
Epithelial structures, the paired lateral anlages, are formed from the ventral portions of
the fourth and fifth branchial pouches. This structure, the well-known ultimobranchial body
(caudal pharyngeal pouch complex), becomes lost in the developing thyroid gland, and its cells
become dispersed as the C (calcitonin) cells among the thyroid follicles.
Present evidence suggests that the primary origin of the calcitonin-producing cells of the
thyroid gland is the neural crest of the embryo. From the neural crest these cells migrate to the
ultimobranchial body, and later become part of the thyroid gland. C cells belong to a group of
6neural-crest derivatives known as APUD (amine precursor uptake and decarboxylation) cells.
Tumors of the APUD system are collectively called "apudomas." Congenital Anomalies
Lingual Thyroid
Occasionally the thyroid gland is not in the normal cervical position, but lies beneath
the epithelium of the tongue, at the site of the foramen cecum.lingual thyroid results from a
failure of the median anlage to descend from the pharynx. The lingual thyroid gland is
usually small but normal and is the only thyroid tissue present. Radioactive iodine
scintigraphy will aid in the diagnosis and will determine the presence of other thyroid tissue
in the patient.
A thyroid gland may be found anywhere along the track from the foramen cecum to
the normal site. Such "partially descended" glands are rare. Total excision of a lingual thyroid
is necessary. It requires care, because the gland is well vascularized by the lingual arteries. In
one series,2 out of 12 lingual thyroids were malignant. If no malignancy is reported from
frozen sections, the excised tissue can be implanted into the anterior abdominal wall.
Persistent Remnants of the Thyroglossal Duct
The foramen cecum of the tongue and the pyramidal lobe of the thyroid gland are normal
remnants of the thyroglossal duct. Thyroglossal duct cysts account for 62.8 percent of all the
congenital masses of the neck.
Primary carcinoma in thyroglossal duct cyst occurs in less than 1 percent of cases. Walton
and Koch presented a case of thyroglossal duct cyst with papillary carcinoma,
Medullary thyroid cancer has not been reported because there are no C cells in the
pyramidal lobe (the parafollicular C cells arise from the lateral thyroid anlage).Frequently,
individuals who have ectopic thyroid also have an absence of normal thyroid. Therefore, before
the ectopic thyroid is excised, it is important to evaluate whether it is the only thyroid tissue in the
7body. Between the foramen cecum and the pyramidal lobe is a very small epithelial tube, usually
broken in several places. Occasionally these epithelial fragments hypertrophy, secrete fluid, and
form cysts. Drainage or aspiration of these cysts is futile and often results in the formation of a
fistula, which usually becomes infected. All fragments of the duct, foramen cecum, and
midportion of the hyoid bone should be removed (Sistrunk procedure). Recurrence of the cyst
is the result of failure to remove the entire duct. Failure to remove the central portion of the
hyoid bone resulted in 17 percent recurrence in one series of operations.
Lateral Aberrant Thyroid
Of special interest —and a vexation to surgeon, pathologist, and patient— is lateral
aberrant thyroid tissue; that is, tissue located lateral to the jugular vein. It has three
morphologic manifestations.
This tissue may be found as a nodule attached by connective tissue to the mother
gland. These thyroid tissue "islands," which pull away from the visceral body during
development, are nevertheless normal.
The second site for lateral thyroid tissue is within lymph nodes or their remnants.
We should consider a cervical lymph node containing thyroid follicles to be clinically
a metastatic thyroid carcinoma. However, the existence of heterotopic thyroid tissue within
cervical glands has been reported.
The final morphologic expression of laterally aberrant thyroid tissue must be termed
congenital. In a patient whose only thyroid tissue, by all appearances, was lateral aberrant
thyroid tissue.
Always consider the possibility of metastatic thyroid cancer of lateral aberrant thyroid
nodules.
8Struma Ovari
Struma ovarii, the ovarian thyroid, is an extraordinary thyroid ectopia, although it is
unrelated to the anatomic thyroid gland and is not a true congenital anomaly. Ovarian thyroid
tissue is a fellow traveller with dermoid cysts and teratoma. Struma ovarii may exist in 0.2-
1.3% of all ovarian tumors. Of these, 5-6% are bilateral and about 5% possess functioning
thyroid tissue. Hyperthyroidism in struma ovarii may be seen in some cases. Malignancy is a
possible occurrence in as many as 5% of all struma ovarii,with metastasis noted in papillary
carcinoma.
9ANATOMY
General Topography
The thyroid gland consists typically of two lobes, a connecting isthmus, and an
ascending pyramidal lobe. One lobe, usually the right, may be smaller than the other (7
percent) or may even be completely absent (1.7 percent). The isthmus is absent in about 10
percent of thyroid glands, and the pyramidal lobe is absent in about 50 percent . A minute
epithelial tube or fibrous cord, the thyroglossal duct, almost always extends between the
thyroid gland and the foramen cecum of the tongue.
The thyroid gland normally extends from the level of the 5th cervical vertebra to the
body of the 1st thoracic vertebra. It may lie higher (lingual thyroid), but rarely lower. The
normal thyroid gland weighs about 30 g in the adult —somewhat more in females than in
males. Each lobe is approximately 5 cm in length, 3 cm at its greatest width, and 2-3 cm
thick. The isthmus connecting the two lobes is about 1.3 cm in breadth. The lobes have a
broad lower portion and a relatively conical apex.
Capsule of the Thyroid Gland
The thyroid gland has a connective tissue capsule which is continuous with the septa,
and which makes up the stroma of the organ. This is the true capsule of the thyroid.
External to the true capsule is a well developed (to a lesser or greater degree) layer of
fascia derived from the pretracheal fascia. This is the false capsule, also called the perithyroid
sheath or surgical capsule. Anteriorly and laterally this fascia is well developed; posteriorly it is
thin and loose, permitting enlargement of the thyroid gland posteriorly. There is a thickening of
the fascia that fixes the back of each lobe to the cricoid cartilage. Such thickenings are the
ligaments of Berry. The false capsule, or fascia, is not removed with the gland during
thyroidectomy.
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The superior parathyroid glands normally lie between the true capsule of the thyroid
and the fascial false capsule. The inferior parathyroids may be between the true and false
capsules, within the thyroid parenchyma, or lying on the outer surface of the fascia. The
levator muscle of the thyroid is one or more muscular slips that occasionally connect the
hyoid bone with the thyroid gland. These vestigial muscles are inconstant in occurrence,
location, and innervation. They have been divided into anterior, lateral, and posterior
levators.
Vascular Supply
The thyroid gland competes with the adrenal glands for having the greatest blood
supply per gram of tissue. One consequence is that hemostasis is a major problem of thyroid
surgery, especially in patients with toxic goiter.
Arteries
Two paired arteries, the superior and inferior thyroid arteries, and an inconstant
midline vessel, the thyroid ima artery, supply the thyroid .
Superior Thyroid Artery
The superior thyroid artery arises from the external carotid artery just above, at, or just
below the bifurcation of the common carotid artery. It passes downward and anteriorly to reach
the superior pole of the thyroid gland. In part of its course, the artery parallels the external branch
of the superior laryngeal nerve which supplies the cricothyroid muscle and the cricopharyngeus
muscle, the lowest voluntary part of the pharyngeal musculature.
There are six branches of the superior thyroid artery - the infrahyoid,
sternocleidomastoid, superior laryngeal, cricothyroid, inferior pharyngeal constrictor, and
terminal branches of the artery for the blood supply of the thyroid and parathyroid glands.
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Usually there are two branches to the thyroid —the anterior and posterior— but occasionally
there may be a third, the so-called lateral branch.
The arterial supply of thyroid gland
At the superior pole, the superior thyroid artery divides into anterior and posterior
branches. The anterior branch anastomoses with the contralateral artery; the posterior branch
anastomoses with branches of the inferior thyroid artery. From the posterior branch, a small
parathyroid artery passes to the superior parathyroid gland.
In a study of thyroid glands removed at autopsy from Japanese patients, observed that
an anastomosing vessel from the posterior branch of the superior thyroid artery supplied the
superior parathyroid in 45% of cases. The majority of 92 glands (67%) had a single artery of
supply; 1/3 had two or more small vessels which entered the gland. In the photographs of the
specimens, the branching pattern of the primary vessel supplying the gland appeared to
indicate that its origin was from the superior thyroid artery.
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Branches of superior thyroid artery
Inferior Thyroid Artery
The inferior thyroid artery usually arises from the thyrocervical trunk, but in about 15
percent of individuals it arises directly from the subclavian artery.
The inferior thyroid artery ascends behind the carotid artery and the internal jugular
vein, passing medially and posteriorly on the anterior surface of the longus coli muscle. After
piercing the prevertebral fascia, the artery divides into two or more branches as it crosses the
ascending recurrent laryngeal nerve.
The recurrent laryngeal nerve may pass anterior or posterior to the artery, or between
its branches . The lowest branch sends a twig to the inferior parathyroid gland and supplies
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the lower pole of the thyroid gland. The upper branch supplies the posterior surface of the
gland, usually anastomosing with a descending branch of the superior thyroid artery. On the
right, the inferior thyroid artery is absent in about 2 percent of individuals. On the left, it is
absent in about 5 percent . The artery is occasionally double.
Thyroid Ima Artery
The thyroid ima artery is unpaired and inconstant. It arises from the brachiocephalic
artery, the right common carotid artery, or the aortic arch. It occurs in about 10 percent of
individuals, according to Montgomery. It may be as large as an inferior thyroid artery or it
may be a mere twig. Its position anterior to the trachea makes it important in tracheostomy.
Veins
Veins of the thyroid gland form a plexus of vessels lying in the substance and on the
surface of the gland. The plexus is drained by three pairs of veins, the superior, middle, and
inferior thyroid veins
Superior Thyroid Vein
The superior thyroid vein accompanies the superior thyroid artery. Emerging from the
superior pole of the thyroid, the vein passes superiorly and laterally across the omohyoid
muscle and the common carotid artery to enter the internal jugular vein alone or with
the common facial vein.
Middle Thyroid Vein
The middle thyroid vein arises on the lateral surface of the gland at about two-thirds of its
anteroposterior extent. No artery accompanies it. It crosses the common carotid artery to open
into the internal jugular vein. This vein may be absent or, occasionally, double. The extra vein is
inferior to the normal one; it has been called the "fourth" thyroid vein. The importance of these
middle thyroid veins is in their vulnerability during thyroidectomy.
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Inferior Thyroid Vein
The inferior thyroid vein is the largest and most variable of the thyroid veins; the
right and left sides are usually asymmetric. The right vein leaves the lower border of the
thyroid gland, passes anterior to the brachiocephalic artery, and enters the right
brachiocephalic vein. The left vein crosses the trachea to enter the left brachiocephalic vein.
Rarely, the right vein crosses the trachea to enter the left brachiocephalic vein, sometimes
forming a common trunk with the left vein. This common trunk is called the thyroid ima
vein.
Venous drainage of the thyroid gland
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Lymphatics
Several broad patterns of lymphatic drainage of the thyroid gland have been proposed
. Each conceptualization is based on the same facts; each is correct. We will follow that of
Hollinshead.
Patterns of Drainage
Median Superior Drainage
Three to six vessels arise from the superior margin of the isthmus and from the
medial margins of the lateral lobes. These vessels pass upward in front of the larynx to end in
the digastric lymph nodes. Some vessels may enter one or more prelaryngeal ("Delphian")
nodes just above the isthmus. Secondary drainage may be to upper jugular nodes on either
side or to pretracheal nodes below the thyroid by a vessel passing from the Delphian nodes
downward over the front of the thyroid.
It has been suggested that there is a connection between the lymphatic drainage of the
superior thyroid artery and the orbit by way of the jugular chain of cervical lymph nodes. In
neither the orbit nor the eye itself can lymphatic vessels be demonstrated.
The immediate cause of exophthalmus associated with thyroid disease is the
enlargement of the extraocular muscles, especially the inferior rectus and inferior oblique.
Thyroid antigen or antigen-antibody complexes reaching the eye from the thyroid gland
produce an autoimmune response in the extraocular muscles
Median Inferior Drainage
Several lymph vessels drain the lower part of the isthmus and the lower medial
portions of the lateral lobes. They follow the inferior thyroid veins to end in the pretracheal
and brachiocephalic nodes.
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Right and Left Lateral Drainage
Lymphatic trunks arise from the lateral border of each lobe. Superiorly they pass
upward with the superior thyroid artery and vein. Inferiorly they follow the inferior thyroid
artery.. Between these two groups, some vessels pass laterally, anteriorly, or posteriorly to
the carotid sheath to reach the lymph nodes of the internal jugular chain. Occasionally,such
vessels drain into the right subclavian vein, jugular vein, or thoracic duct without passing
through a lymph node.
Lymphatic drainage of the thyroid gland
Posterior Drainage
Posterior lymphatic vessels arise from the inferomedial surfaces of the lateral lobes to
drain into nodes along the recurrent laryngeal nerve. Occasionally, a posterior ascending
trunk from the upper part of the lobe reaches the retropharyngeal nodes.
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Metastatic Spread
A representation of lymph node regions of importance for management of thyroid
carcinoma and  Lymph node groups at the highest risk for regional metastasis from
differentiated thyroid carcinoma are  shown below.
LN regions of importance for thyroid carcinoma
Innervation
The thyroid gland is innervated by the sympathetic system from the superior, middle,
and inferior ganglia of the cervical chain. But in thyroid surgery the recurrent and superior
laryngeal nerves of the parasympathetic (vagus) system (which play no role in the
innervation of the gland) are of utmost importance, so we consider them here.
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Recurrent Laryngeal Nerves (Inferior Laryngeal)
Normal Anatomy
The right and left recurrent laryngeal nerves are intimately related to the thyroid
gland. The right recurrent nerve branches from the vagus as it crosses anterior to the right
subclavian artery. The right recurrent nerve loops around the subclavian artery from posterior
to anterior, crosses behind the right common carotid and ascends in or near the
tracheoesophageal groove. It passes posterior to the right lobe of the thyroid gland to enter
the larynx behind the cricothyroid articulation and the inferior cornu of the thyroid cartilage.
The left recurrent nerve arises where the vagus nerve crosses the aortic arch, just distal to
the origin of the left subclavian artery from the aortic arch. It loops under the ligamentum
arteriosum and the aorta, and ascends in the same manner as the right nerve. Both nerves cross
the inferior thyroid arteries near the lower border of the middle third of the gland.
Variations
Several variations may occur in the courses of the recurrent nerves. All serve to
increase the possibility of injury to the nerve during thyroid surgery.In about 1 percent of
patients, the right recurrent nerve arises normally from the vagus, but passes medially almost
directly from its origin to the larynx without looping under the subclavian artery. In these
cases, the right subclavian artery arises from the descending aorta and passes to the right
behind the esophagus. This anomaly is asymptomatic, and the thyroid surgeon will rarely be
aware of it prior to operation. Even less common is a nonrecurrent left nerve in the presence
of a right aortic arch and a retroesophageal left subclavian artery.
In the lower third of its course, the recurrent laryngeal nerve ascends behind the
pretracheal fascia at a slight angle to the tracheoesophageal groove. In the middle third of its
course, the nerve may lie in the groove, medial to the suspensory ligament of the thyroid
gland (ligament of Berry), within the ligament, or within the substance of the thyroid
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gland.The recurrent laryngeal nerve is safest and least visible when it lies in the
tracheoesophageal groove. It is most vulnerable when it traverses the thyroid parenchyma.
Where it runs in the suspensory ligament of the thyroid, it must be identified and protected
before the ligament is divided.
The recurrent laryngeal nerve crosses the inferior thyroid artery at the middle third of the
gland. It may lie anterior or posterior to, or between the branches of the artery. the secret to
avoiding injury to the recurrent laryngeal nerve during thyroid surgery is as follows: (1) deep
knowledge of the surgical anatomy of the thyroid region; (2) total extracapsular
thyroidectomy; (3) a thorough search, identification, and exposure of the nerve itself; and (4)
following the course of the nerve with care.
Superior Laryngeal Nerve
The superior laryngeal nerve arises from the vagus nerve just inferior to its lower
sensory ganglion just outside the jugular foramen of the skull. The nerve passes inferiorly,
medial to the carotid artery. At the level of the superior cornu of the hyoid bone it divides
into a large, sensory, internal laryngeal branch and a smaller, motor, external laryngeal
branch, serving the cricothyroid muscle and the cricopharyngeus. The point of division is
usually within the bifurcation of the common carotid artery.
20
The course of recurrent laryngeal nerve at the thyroid gland.
Internal Laryngeal Nerve
The internal laryngeal branch pierces the thyrohyoid membrane with the superior
laryngeal branch of the superior thyroid artery to enter and supply the larynx. The internal
branch is rarely identified by the surgeon; identification occurs only in those cases where a
greatly enlarged upper pole of the thyroid gland rises above the superior border of the thyroid
cartilage . The internal laryngeal nerve provides general sensory fibers to the larynx and the
area of the piriform recess of the laryngopharynx. It also provides parasympathetic fibers for
the glandular elements and some taste fibers that supply taste buds around the epiglottis.
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External Laryngeal Nerve
The external laryngeal branch, together with the superior thyroid vein and artery,
passes under the sternothyroid muscles, posterior and medial to the vessels. The nerve then
passes beneath the lower border of the thyrohyoid muscle to continue inferiorly to innervate
the cricothyroid muscle. In addition to its contribution to phonation, the cricothyroid muscle
plays a major role in the overall regulation of breathing by its control of expiratory resistance
and flow. a branch of the external laryngeal nerve may also contribute to the innervation of
the thyroarytenoid muscle and to the sensory supply of the vocal fold of the larynx. They
postulated that the communicating branch of this nerve might represent the nerve of the 5th
embryonic branchial arch.
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HISTOLOGY
The thyroid gland is surrounded by the thyroid capsule, which is a thin layer of
connective tissue. From the capsule, several septa extend within the thyroid parenchyma,
which is subdivided into several lobules. Epithelial cells (cuboidal or squamous) form the
thyroid follicles; they are separated by thin connective stroma which is rich in both lymphatic
and blood vessels. Small bundles of nerves are present.
There is a colloidal gelatinous collection in the center of the follicle. Each follicle has
two types of cells: follicular and parafollicular, or C cells.
According to Ross and Reith, the follicular cells are responsible for the following
actions: synthesis of thyroglobulin, iodination, storage of thyroglobulin, resorption of
thyroglobulin, hydrolysis of thyroglobulin, and release of thyroid hormone into the blood and
lymphatics.
The parafollicular, or C cells, can be found in the connective stroma between the
follicles or in the follicular epithelium. Characteristically, they contain several secretory
granules.
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PHYSIOLOGY
The thyroid gland weighs 20 to 25 g in normal adults and is responsible for the
production of two families of metabolic hormones, the thyroid hormones, thyroxine (T4) and
triiodothyronine (T3), and the calcium-regulating hormone, calcitonin. The spherical thyroid
follicular unit is the important site of thyroid hormone production. The follicular unit is made
up of a single layer of cuboidal follicular cells that encompass a central depository of colloid
filled mostly with thyroglobulin (Tg), the protein in which T4 and T3 are synthesized and
stored.
Iodine Metabolism
Iodine is essential for the production of thyroid hormones. It can be efficiently
absorbed from the gastrointestinal (GI) tract in the form of inorganic iodide and rapidly
enters the extracellular iodide pool. The thyroid gland is responsible for storing 90% of total
body iodide at any given time, with less than 10% existing in the extracellular pool. Iodide is
stored in the thyroid as preformed thyroid hormone or as an iodinated amino acid. Iodide is
transported from the extracellular space into the follicular cells against a chemical and
electrical gradient via an intrinsic transmembrane protein located in the basolateral
membrane of the thyroid follicular cells. Once inside the cells, iodide rapidly diffuses to the
apical surface, where it is quickly moved to exocytic vesicles. Here, it is rapidly oxidized and
bound to Tg. Transport of iodide into follicular cells is regulated by thyroid-stimulating
hormone (TSH) from the pituitary gland, as well as by the follicular content of iodide. The
relationship between iodine ingestion and thyroid disease has been known for more than 100
years. At the turn of the 20th century, the practice of iodine supplementation of food and
water came about as a result of careful study in areas in which iodine insufficiency was found
and linked to endemic goiter. Significant iodine deficiency still occurs in various
undeveloped parts of the world. Iodine deficiency can result in nodular goiter,
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hypothyroidism, and cretinism, and possibly the development of follicular thyroid carcinoma
(FTC)
Thyroid Hormone Synthesis
Once organic iodide is efficiently oxidized and bound, it couples to Tg with tyrosine
moieties to form iodotyrosines in a single conformation (monoiodotyrosine [MIT]) or a
coupled conformation (diiodotyrosine [DIT]; ). The formation of DIT and MIT is dependent
on an important intracellular catalytic agent, thyroid peroxidase, which has been well
characterizedand is an integral part of the initial process of organification and storage of
inorganic iodide. This enzyme, along with Tg, is remarkably specific to the thyroid follicular
cells, making bothimportant in the diagnosis and management of autoimmune thyroid disease
and well differentiated thyroid cancer. MIT and DIT are biologically inert. Coupling of these two
residues gives rise to the two biologically active thyroid hormones, T4 and T3. T4 is formed by
the coupling of two molecules of DIT, whereas T3 is formed by the coupling of one molecule of
MIT with one molecule of DIT. In normal circumstances, formation of T4 predominates. Both
T3 and T4 are bound to Tg and stored in the colloid in the center of the follicular unit, which
allows quicker secretion of the hormones than if they had to be synthesized de novo. This
rapid and metabolically active process normally results in the storage of about 2 weeks’
worth of thyroid hormone in the organism under normal circumstances. Most thyroid
hormone released from the thyroid gland is T4, which is deiodinated in peripheral
extrathyroidal tissues and converted to T3. Release of T4 and T3 is regulated by the apical
membrane of the follicular cell via lysosomal hydrolysis of the colloid that contains the Tg-
bound hormones. The apical membrane of the thyroid cell forms multiple pseudopodia and
incorporates Tg into small vesicles, which are then brought into the cell apparatus. Within the
vesicles, lysosomal hydrolysis results in the reduction of the disulfide bonds and T3 and T4
are then free to pass through the basement membrane and be absorbed into the circulation,
where more than 99% of each hormone is bound to serum proteins. This metabolic process is
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efficient in releasing T3 and T4 while maintaining the storage components, Tg and colloid,
within the follicular apparatus. Although sensitive assays of peripheral blood can measure
Tg, peripheral Tg represents an extremely small fraction of total body stores. Residual
iodotyrosines undergo peripheral breakdown, deiodination, and recycling and can then be
added to the recently absorbed iodide stores and become available for the synthesis of new
thyroid hormone .
Thyroglobulin
Tg is a 660-kDa glycoprotein specific to the follicular cell that is the primary component
of the colloid matrix necessary for iodination and hormonogenesis. Tg facilitates theconversion
of MIT and DIT into T3 and T4. This process is accompanied by the escape of small amounts
of Tg into the peripheral bloodstream, where it can be assayed. TSH enhances the whole
process of endocytosis, proteolysis, and release through an adenylate cyclase system. Excess
peripheral levels of iodine inhibit further release by enhancing Tg resistance to proteolysis.
Peripheral Tg can be measured to evaluate benign or malignant thyroid neoplasms.
Measurement of peripheral Tg has predictive value for the recurrence of well-differentiated
thyroid carcinoma, locally or in metastatic deposits after initial total thyroidectomy.
However, the usefulness of measuring serum Tg levels prior to the initial resection of a
known or suspected welldifferentiated thyroid cancer is unknown and its routine
measurement is not recommended.
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Fig – 14. Diagrammatic scheme of thyroid hormone formation and secretion. 1, Tg
and protein synthesis in the rough endoplasmic reticulum. 2, Coupling of the Tg
carbohydrate units in the smooth endoplasmic reticulum and Golgi apparatus. 3, Formation
of exocytotic vesicles. 4, Transport of exocytotic vesicles with noniodinated Tg to the apical
surface of the follicle cell and into the follicular lumen. 5, I odide transport at the basal cell
membrane. 6, I odide oxidation, Tg iodination, and coupling of iodotyrosyl to iodothyronyl
residues. 7, Storage of iodinated Tg in the follicular lumen. 8, Endocytosis by
micropinocytosis. 9, Endocytosis by macropinocytosis (pseudopods). 10, Colloid droplets.
11, Lysosome migrating to the apical pole. 12, Fusion of lysosomes with colloid droplets. 13,
Phagolysosomes with Tg hydrolysis. 14, T3 and T4 secretion. 15, MIT and DI T
deiodination.
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Regulation of Thyroid Hormone Secretion
The hypothalamic-pituitary-thyroid axis regulates thyroid hormone production and
release in a classic endocrine feedback system. The major regulator of thyroid gland activity is
the glycoprotein TSH, which is a major growth factor for the thyroid. TSHstimulates thyroid
cell growth and differentiation, as well as iodine uptake and organification and release of T3
and T4 from Tg. Also, TSH has been shown to stimulate the growth and invasive
characteristics of some well-differentiated thyroid cancer cell lines in vitro. TSH is a 28-kDa
glycoprotein secreted in a pulsatile fashion by the anterior pituitary gland. It has two
components; the α subunit is common to other anterior pituitary hormones but the β subunit
is unique to TSH and determines the hormone’s biologic specificity. Once TSH activates the
receptor (TSH-R), it interacts with a guanine nucleotide–binding protein (G protein),
stimulating the production of cyclic adenosine monophosphate (cAMP). This cAMP pathway
is an important hormone-synthesizing event. Receptors coupled with G proteins have seven
transmembrane-spanning domains, with cytoplasmic and extracellular loops. The first three
of these cytoplasmic loops have important relationships in mediating the TSH-dependent
increase in cAMP production and therefore in stimulating thyroid hormone production. The
receptors that respond to TSH have been identified and cloned. Specific mutations in the
genetics of this system have been identified and are associated with follicular thyroid
neoplasms. The feedback loop is an important regulator of TSH secretion. Increased
thyrotropin-releasing hormone (TRH) from the paraventricular nucleus of the hypothalamus
and reduced levels of T3 stimulate release of TSH from the anterior pituitary. TRH is a
three–amino acid peptide that passes through the hypothalamic portal system into the median
eminence and through the pituitary stalk to the anterior pituitary. Peripheral thyroid hormone
levels may, in addition to stimulating release of TSH from the anterior pituitary, enhance
TRH secretion. Many pathologic states result in increased peripheral levels of T3 and T4,
which decrease TSH secretion by a negative feedback loop. Peripheral T4 is locally
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deiodinated in the pituitary and converted to T3, which then directly inhibits the release and
synthesis of TSH. The condition that usually decreases TSH secretion is classified as primary
hyperthyroidism. It has many causes, including many types of thyroiditis, Graves’ disease,
autonomously functioning thyroid nodules, and conditions that increase human chorionic
gonadotrophin (hCG) levels, such as gynecologic malignancies and overuse of exogenous
thyroid hormone. Decreased levels of TSH can also be caused by abnormalities at the level of
the pituitary and/or hypothalamus, which are collectively termed central hypothyroidism.
These conditions are much rarer than primary hyperthyroidism. Although TSH is the primary
regulator of thyroid hormone synthesis, intrinsic autoregulatory mechanisms are alternative
routes whereby the thyroid can control intraglandular stores of thyroid hormones. In areas in
which dietary iodide is excessive, the thyroid gland has an autoregulated process that inhibits
the uptake of iodide into follicular cells. The reverse is true in iodide deficiency. Excessively
large doses of iodide have complex effects. These include an increase in organification
followed by cessation of production, a syndrome known as the Wolff- Chaikoff effect.
Peripheral Action of Thyroid Hormones
In the periphery, T3 is significantly more potent than T4. Most T4 is converted to T3,
which has a high affinity for the peripheral nuclear thyroid hormone receptor (TR), a member of
the steroid hormone receptor family. Therefore, the action of thyroid hormones in the periphery
consists predominantly of the interaction of T3 with the nuclear TR, which then binds to
regulatory regions in various gene-regulated processes. Two genes regulate TR production and
activity, the α and β forms, which are located on chromosomes 17 and 3 . The β form of TR is
contained within the liver; the central nervous system contains predominantly an α form of
TR.
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Cellular and molecular events involved in thyroid hormone function. T4 is converted
in the periphery and in the cytoplasm of the cell into T3. T3 travels to the nucleus, where it
binds to the thyroid hormone receptor (TR; homodimer, monomer, or heterodimer). TR
binding leads to R NA transcription in association with other transcription factors; messenger
R NA is subsequently expressed and then translated into protein.
The clinical result of thyroid hormone action is regulated through TR and its effect on
various genes, expressions of which are then regulated in the nucleus via the production of
polypeptides. For example, T3 acts on the pituitary by regulating transcription of the genes
for the α and β subunits of TSH, which results in TSH secretion. T3 affects cardiac
contractility by regulating the transcription of myosin heavy chain production in cardiac
muscle. Of circulating T3 and T4, 80% is bound to thyroxinebinding globulin (TBG) in the
periphery. A number of medications and clinical scenarios alter serum levels of TBG or the
affinity of TBG for circulating thyroid hormone .
Also, T4 is bound to prealbumin and albumin. In pregnancy and other clinical
situations with elevated estrogen levels, such as oral contraceptives, menopausal estrogen
replacement therapy, and tamoxifen or raloxifene use (selective estrogen receptor
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modulators), TBG levels are significantly increased, thereby resulting in higher levels of
bound T4 (total) in the periphery. Other causes of increased TBG concentrations include
heroine or methadone use, clofibrate, and 5-flurouracil (chemotherapeutic agent). In contrast,
decreased TBG levels are caused by agents such as anabolic steroids (testosterone), nicotinic
acid, and corticosteroids.
Such states are clinically euthyroid, however, because free T4 levels are not altered. Most
T3 and T4 are bound to the extent that free T4 constitutes less than 1% of peripheral hormone.
The bound form of thyroid hormone cannot pass from the extracellular space and must be in the
free form to diffuse into extracellular tissues to affect major metabolic activity. T3 is especially
important in this regard. The process whereby T3 and T4 dissociate from binding protein and
diffuse into extracellular tissues is an efficient process that allows tight control of peripheral
metabolic activities. Most T3 isperipherally derived from the deiodination of T4, which takes
place largely in the plasma and liver. Other deiodination processes are found in the central
nervous system, especially the pituitary gland and brain tissues, as well as in brown adipose
tissue. Peripheral conversion of T4 to T3 can be impaired in many clinical circumstances,
such as overwhelming sepsis and malnutrition, thionamide (propylthiouracil) use, high-dose
corticosteroids, beta blockers, iodinated contrast agents, and amiodarone use . The half-life of
T3 is approximately 8 to 12 hours and free levels disappear rapidly from the peripheral
circulation. In adults, the half-life of T4 is approximately 7 days because of the efficient and
significant degree of binding to carrier proteins. Therefore, thyroid hormones generally have
a slow turnover time in the peripheral circulation and the body is ensured of at least a 7- to
10-day supply of T4 available for peripheral metabolism. A number of medications are
known to stimulate the degradation of thyroid hormone .
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Inhibition of Thyroid Synthesis
Drugs Antithyroid medications are an option for the treatment of thyroid excess
states. The thionamide class of antithyroid drugs includes propylthiouracil (PTU) and
methimazole (Tapazole). This class of drugs acts by inhibiting the organification and
oxidation of inorganic iodine, as well as by inhibiting linkage of the initial iodotyrosine
molecules MIT and DIT. In addition to these effects, PTU inhibits the peripheral conversion
of T4 to T3. Because of this added capability, PTU is a popular choice for the rapid treatment
of hyperthyroid conditions.
Methimazole has longer activity and requires a single daily dose; it is the preferred
agent in nonpregnant individuals. Both drugs can cause agranulocytosis but this occurs in
less than 1% of cases. Other side effects include rash, arthralgias, neuritis, and liver
dysfunction (potentially worse with PTU). Also, they can act in the periphery to inhibit the
peripheral conversion of T4 to T3. This effectively lowers serum T3 levels, thus allowing
steroids to be used as a rapid inhibitory agent for hyperthyroid conditions. Steroids can also
lower serum TSH concentration. Patients with thyrotoxicosis have increased adrenergic
stimulation. Although beta blockers do not directly inhibit thyroid hormone synthesis per se,
they are valuable in controlling peripheral sensitivity to catecholamines by blocking their
effects. Therefore, cardiovascular symptoms such as an increased pulse rate, tremor, and
anxiety can be improved, but the hypermetabolic state can remain or progress with this
treatment alone. Iodine Iodine, given in large doses after the administration of an antithyroid
medication, can inhibit thyroid hormone release by altering the organic binding process
(Wolff-Chaikoff effect). This stunning effect is transient, but iodine supplementation can be
used to treat hyperactivity of the gland in preparation for surgery.
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EPIDEMIOLOGY AND INCIDENCE
Disorder of thyroid including the ‘Solitary nodule’ occur worldwide,  palpable
thyroid nodule in Euthroid individual is common in clinical practice occurring upto 4% of
general population, their incidence increase with age. Autopsy finding disclose even a higher
incidence, most series reports an incidence of 5-10%,in postmortem series of persons in
whom the nodule was previously undetected during life. However, clinical interest in the
nodule is disproportionate to actual biological significance since majority will be related to
multinodular goiter.
In contrast, however, a true solitary thyroid nodule, accounting for up to
approximately 25% of clinically detectable solitary thyroid nodule is important both
clinically and pathologically since although most of the case turn out be benign, 10-30% will
harbour malignant neoplasm . The incidence of malignancy in solitary nodule who undergo
surgery is increasing chiefly due to improved selection of patients for surgery.
SEX INCIDENCE:
Thyroid disorders are preponderantly confined to females in the ratio of 6:1 and this
is due to variations of thyroid hormone demand during female reproductive function,
physiological events such as puberty, pregnancy, lactation. Incidence of solitary nodule is
also higher in females.But incidence of Malignancy in solitary nodule is more in men (26%)
compared to female (9%)
AGE INCIDENCE:
Thyroid nodules occur at all ages, the reported age range from 15-69 years with
maximum incidence in 30-40 years. Solitary nodule is rare in children, the incidence of
carcinoma in such a nodule under 25 years of age is about 50% and 75% in patient under 15
years.
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INCIDENCE OF MALIGNANCY IN SOLITARY NODULE OF THYROID:
Though commonest cause of solitary nodule is not carcinoma, a significant proportion
is carcinomatous. In general between 10-20% of solitary nodule removed surgically is
malignant.
Solitary nodule found in thyroid of patient less than 20 years and greater than 60
years carries far greater risk of being malignant. Solitary nodule of thyroid can arise from
diverse causes. The common causes of  solitary thyroid nodules are adenomatous goiter,
neoplasm and chronic thyroiditis.
The aetiology of the nodule depends upon the population under study, sex , age of
patient and prior history of exposure to ionizing radiation.
In practice, a clinical diagnosis of solitary thyroid nodule is, in fact, a dominant
nodule of multinodular goiter is 50% of cases , as shown on subsequent investigations any
dominant nodule within a multinodular goiter should be essentially treated as solitary thyroid
nodule , as they have incidence of malignancy of around 10%.
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AETIOLOGICAL FACTORS
A- Aetiology of adenomatous nodules:
Adenomatous goiter occur as a result of compensatory mechanism against deficient
synthesis of thyroid hormone by the thyroid gland. The hormone by the thyroid follicles is
regulated by TSH, secreted by anterior pituitary which in turn is regulated by negative
feedback mechanism by the levels of thyroid hormone in blood and by TRH sercreted by
hypothalamus. When there are low levels of T3 and T4 in blood they stimulate anterior
pituitary to secrete TSH , which acts on follicular cell, induces hyperplasia, and hypertrophy
to trap iodine and synthesis more of T3 andT4 . The hyperplasia may not occur uniformly,
several foci of hyperplasia may result ,of which some are large, some small. Following
hyperplasia there is involution after need for T3and T4 decrease . Repeated stimulation of
thyroid causes hyperplasia and involution of varying degrees end also degenerative changes
and fibrosis resulting in nodularity. If among various nodule only one of them attain large
size which cannot be detected clinically, a solitary adenomatous nodule ensues.
Iodine deficiency in endemic area results in endemic area results in highest incidence
of goiter and greater than 50% prevalence is found in extreme iodine deficient area. Iodine
deficiency alone always does not cause goiter. There is unusual geographic distribution of
goiter with some areas more severely affected than other
B) AETIOLOGY  OF THYROID NEOPLASMS:
a) Radiation: The relationship between ionizing radiation and development of benign
adenomas and malignant tumors is well known. Thyroid exposure to radiation can occur in
two ways.
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External sources
Internal source.
External exposure can be because of medically administered external beam
radiationor environmental exposure previously related to nuclear weapons attack or
weaponstesting and more recently nuclear power plant accidents.
Internal  injection of isotopes of iodine which is concentrated  inthe thyroid gland
can come from the ingection of the isotopes  and from thefallout of nuclear weapons ,
explosion or power plant accitents.
The carcinogenic radiation is by 2 mechanisms
1. Cellular injury with altered cell division and replication of nucleic acids.
2. The injured cells produce less thyroid hormone leading to TSH stimulation which
is itself cardiation exposure include:
a) Amount of radiation received
b) Duration of radiation received
c) Age at which radiation was received
d) Latent period
Low dose radiation for Tinea capitis (6-5 cGy), thymic enlargement (100 to400 cGy),
enlarged tonsils and adenoids (750Egy) Acne vulgaris (200 to 1500 cGy) are best known
etiological factor . The risk increases linearly from 6.5 to 2000 cGy, beyondwhich the
incidence decline as radiation causes destruction of thyroid tissues. The risk maximum 20 to
30 years after exposure. Approximately 30% of exposed children develop thyroid nodules
and of these estimated 30% are malignant.
36
B) Ingestion of radioisotopes and malignancy :
The most common exposure is due 131 I administered for diagnostic thyroid scans. A
typical scan exposes the thyroid to approximately 50 rads of external beam radiation. Studies
have shown that is only a small increase in the of incidence of malignancies of thyroid after
exposure to this dose.
A more dangerous type of ingestion of radioisotopes  comes from exposure to nuclear
fallout . contrary to medically administered 131 I and short lived radio - isotopes such as 129
I and 131-135 I.
Vast majority of patients developing post radiation malignancy have papillary
histology.
c) Diet
There is an increased  incidence of follicular cancer in iodine deficient endemic
goiterous areas as well as an papillary carcinoma in iodine rich regions.
d) Sex:
Factors such as parity, early menopause, contraceptive use and late age at first birth in
female population have been reported to have increased risk of thyroid carcinoma but the
data been inconsistent.
The thyroid nodule is more likely to be a cancer in men than in men than in women and
in young (under 20 years) and older (over 60 years) patients rather than others.
e) Genetic predisposition:
There is no clear familial syndrome or genetic dis ease associated with non-medullary
thyroid carcinoma.
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Loose associations with familial polyposis of colon including Gardner’s syndrome,
Cowden’s syndrome, melanomas, testicular and bladder cancer have been reported. This
contrasts with medullary thyroid carcinoma, which has a variety of genetic syndromes now
being defined at molecular levels. The familial medullary carcinoma syndromes is
transmitted as an autosomal dominant trait and thus 50% of the offspring would be expected
to have this disease
C) Aetiology of chronic thyroiditis (Hashimoto’s thyroiditis):
Hashimoto’s thyroiditis is clearly autoimmune in nature and may be the most
common autoimmune disorder as well This occurs as a painless diffuse goiter in young or
middle age women and often presents as an incidental finding during routine physical
examination.
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PATHOLOGY
1) Colloid (adenomatoid) nodule:
This goiter is mainly due to stimulation with increased TSH. THS secretion is
increased due to low level of circulating thyroid hormones. Simple goiter are more common
in females than in males owing to the presence of estrogen receptors in thyroid tissue.
Persistent growth stimulation causes diffuse hyperplasia, all lobules are composed of active
follicles and iodine uptake is uniform. If TSH stimulation ceases, the goiter may regress. The
goiter is soft diffuse and may become large enough to cause discomfort. A colloid goiter is a
late stage of diffuse hyperplasia when TSH stimulation has fallen off and follicle are inactive
and full of colloid.
Latter as a result of fluctuating stimulation of TSH, a mixed pattern develops with
areas of active lobules and areas of inactive lobules. Active lobules become more vascular
and hyperplastic until hemorrhage occurs, causing central necrosis and leaving only a
surrounding rim of active follicle. Necrotic lobules coalesce to form nodules filled either with
iodine – filled colloid or mass of new but inactive follicles.
Continual repetition of this process result in a nodular goiter. Most nodules are
inactive and active follicles are present only in the internodal tissue.
Nodules are usually multiple forming a multinodular goiter. A toxic multinodular
goiter usually develops in a large, long standing multinodular goiter of atleast 10 year
duration, only one macroscopic nodule is found but microscopic changes will be present
throughout the gland, this is one form of clinically solitary nodule. Nodules may be colloid,
cellular and cystic degeneration and haemorrhage are common.
39
Adenomatous nodule:
Gross appearance: surface appears nodule , many times more than single nodule may
be detected, cut surface usually shows a circumscribed nodule, Ranging from half a
centimeter several centimeter ton several centimeters in diameter.
Adenomatous goiters  are known to undergo cystic change . Focal haemorrhage,
fibrosis and calcification are common. Microscopy: Nodules appears as clusters of small
active looking follicles  within lobules. Some follicles become  colloid cysts due loss of their
walls . Focal areas of necrosis with collection of red cell s and macrophages laden with
Hemosiderin is also seen.
CLASSIFICATION OF ADENOMAS
Adenomas can be classified into Follicular adenoma and its variants Paqillary
adenoma and Atypical  adenoma
a) Follicular  adenoma:
Almost all thyroid adenoma show follicle formation to a varying degree; follicle
adenoma are usually but may contain a variable amount of colloid; It is unknown whether
follicular adenomas show transition over time. The most important clinically relevant fact
about follicular adenomas is that many of these tumors cannot be reliably distinguished from
follicular carcinoma on clinical, isotopic, USG or FNAC only reliable method of making
distinction by careful histological for evidence of capsular or angio invasion.
Macroscopically:
Degenerative changes such as cyst formation and hemorrhage are common. It is
difficult to differentiate between an adenoma and has a well demarcated capsule, it goes in
favour of adenoma.
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Microscopically :
Follicular adenomas show constant of follicles. Tumor is surrounded by fibrous
capsule, that often contains wide vascular spaces. The tumour cells from large and small
follicles which confine to the inner margin of the capsule. According to the size of follicles
and the degree of follicle formation, follicular adenomas are further classified as
1. Colloid adenoma [macrofollicular adenoma]
2. Simple adenoma [normofollicular adenoma]
3. Fetal adenoma [microfollicular adenoma]
4. Hurthle cell adenoma [follicular adenoma of oxyphilic cell type]
5. Embryonal adenoma ( trabecular adenoma)
6. Follicular adenoma of clear cell type a typical adenoma
8. Atypical follicular of clear cell type.
9. Toxic adenoma ( Hyper-functioning adenoma)
Hurthle cell adenoma (Askanazy or Langhans tumor ) :
Hurthle cell neoplasm are composed of large frequently polygonal, eosinophilic cells
with an abundance of fine granular cytoplasm. They comprise approximately 4.5% to 10% of
all primary epithelial thyroid tumor. Gross: It is  grayish brown in colour and solid on cut
surface The central hyaline scar so characteristic of fetal adenoma is absent  Most of these
have distinct capsule it may be focally cystic or haemorrhagic.
Microsopy :
It is composed of Hurthle cells approximately 10-15 microns in diametetr with
abundant eosinophilic granular cytoplasm and distinct cell membrane and round to oval
nuclei that are larger than the nuclei of normal follicular cells often containing one or more
nuclear, cytoplasmic invagination  and single or multiple homogenous electron dense bodies
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within mitochondrial matrix. Hurthle cell is generally believed to be variant of, or arise from
follicular cells within thyroid.
Hurthle cells are also associated with other non-neoplastic inflammatory conditions
viz. thyroiditis, Grave’s disease and nodular lesions of thyroid. In absence of any capsular or
invasion on HPE, hurthel cell neoplasm should be considered benign.
Embryonal adenoma (trabecular adenoma):
These are the most poorly differentiated of the follicular group. It is fleshy and
densely cellular composed of columns of small, closely packed polyhedral cells after
growing in branching cords with to tendency towards follicle formation. They are very rare.
It neither is present at birth nor does it arise from rests of immature tissue. It arise from
definitive thyroid epithelium. The term only implies that there is resemblance of such lesion
developing thyroid.
Toxic adenoma:
This lesion is a true follicular adenoma but has become autonomous and secretes
excess of thyroxin to produce toxicity. Since these toxic nodules have capacity to grow and
function, independent of trophic hormone, a neoplastic pathogenic basis for these lesions is
preferable.
Gross:
These are circumscribed lesions, which may be solitary with a capsule. It may involve
a part or whole of the lobe. The uninvolved tissue can be identified With features consistent
with atrophy.
Micro :
Features are those of follicular adenoma cells, tend to be columnar withsmall and
large follicles containing pale watery colloid.
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b) Papillary adenoma:
Papillary adenoma is a very rare neoplasm composed of benign papillae with fibrous
stroma but without capsular invasion. This tumor is often cystic and is sometimes referred to
as papillary cystadenoma. This tumor should not be confused with an encapsulated papillary
carcinoma. About 5% of papillary carcinoma are encapsulated without gross evidence of
invasion.
Diagnosis of benign papillary adenoma should be made only if nuclei have slight or
pleomorphism and an extensive search fail to demonstrate invasion of capsule, blood vessels
of  adjacent  parenchyma.  Some  pathologists consider all papillary tumors as malignant, and
it may be difficult to exclude invasion, some others refer this as follicular adenoma with
papillary hyperplasia structures which prompt Confusion.
c) Atypical adenoma:
These are occasionally encountered, described as ground of tumor which display
unusual icroscopic features such as cellular hyper-chromatasia, bizarre nuclei from squamous
islands and spindle cell growth pattern. This comprises about 2-3%. Hazard establised that
atypical adenoma have histologic architecture of carcinoma but have a benign behavior, he
emphasized the importance of invasiveness and stated that encapsulated tumour without
evidence of capsular or blood vessel invasion were benign.
Gross : These are solid and have fleshy appearence and completely defined by
capsule. They  lack the gelatinous or semi translucent character of usual adenoma they are
firm to hard.
Micro: They are cellular with compactly arranged cells than other adenomas Hazard
sub-classified them as;
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Follicular type -clearly packed follicles.
Solid type- cells in sheets or columns
Alveolar type –Organised but solid.
Focal atypical type-In diffuse cellular mass.
It is important to rule out capsular or vascular invasion to confirm benignity. III)
Malignant neoplasms of thyroid :
Classification of malignant neoplasm of thyroid:
a) Well differentiated thyroid carcinoma
i) Papillary carcinoma
ii) Follicular carcinoma
b) Poorly differentiated thyroid carcinoma;
i) Hurthle cell carcinoma.
ii) Variants of papillary carcinoma:
Tall cell variant.
Insular variant.
Columnar variant.
c) Medullary carcinoma.
d) Undifferentiated (Anaplastic) carcinoma
e) Others (rare)
- Lymphoma
- Squamous cell carcinoma.
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- Sarcoma
- Metastatic tumors.
a) Well deffeerentiated thyroid  carcinoma:
i) Papillary carcinoma of the thyroid :
Papillary CA is the most common thyroid CA in both children and adults with
incidence of 62%. It frequently presents in 4th and 5th decades with male to female ratio of
1:3 nearly over ¾ of malignant thyroid tumor in children and young adults for acne and
tonsillitis have been shown to result in an increased incidence of well Differentiated papillary
carcinoma at any time usually 5 years after exposure. There is convincing evidence for an
increase in incidence in incidence of papillary carcinoma in Hashimoto’s thyroiditis.
Multicentricity of primary tumour is the most important feature of this cancer. It
spreads via intraglandular lymphatics within the most important feature of this cancer. It
spreads via intragludular lymphatic within the thyroid gland and then to the subcapsular and
pericapsular lymphnodes. In one large series, the disease was localized to the thyroid gland in
67% of cases, thyroid and Lymph nodes in 13%, and lymphnode alone in 20%.
Minimal or  occult / microcarcinoma tumors are defined as tumours of 1cm or less in
size. They are non-palpable and usually incidental finding at operative, histologic or autopsy
examination. Occult papillary  thyroid cancer is present in 2 to 36% of thyroid glands
removed at autopsy.
Papillary carcinoma is associated with excellent prognosis (10 years survival rate is
95%).
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GROSS: Papillary CA are usually non encapsulated hard, off white, sclerotic tumour
with an irregular margin. Some are well encapsulated and resemble follicular adenoma.
Macroscopic papillae or cyst formation may be present. On occasion, the carcinoma diffusely
infiltrate the gland. At other times the carcinoma may be so small as to be discovered only
incidentally in a microscope section from thyroid removed for an unrelated lesion.
Multicentricity is present in 20-60% of cases depending on exclusiveness of sampling.
Micro: Histologic diagnosis is made on the basis of papillary architecture or
characteristic nuclear features. True papillae have fibrovascular core and are generally lined
by single row of overlapping nuclei. The nuclei of These have been designated ground glass
nuclei, optically clear nuclei or orphon-annie nuclei. They are best appreciated on formatting
fixed permanent sections. They are not seen on alcohol fixed fine needle aspirate smears and
are occasionally and very focally seen on frozen section. Occasional sharply delineated intra
nuclear cytoplasmic inclusions are seen in about half of papillary CA. They are more easily
appreciated on touch imprints and fine needle aspirated smears than on formalin fixed
sections.
Recently, there is increasing attention to grooved nucleus resulting from deep in
folding of nuclear membrane along axis of nucleus. Like all other nuclear features, it is not
100% specific for papillary CA. Psammoma bodies-calcific areas that are laminated, (quite
specific for papillary carcinoma)are seen in less than half of papillary CA and are rarely
present in other thyroid lesions. They are believed to represent remains of dead papillae.
Diagnosis of papillary CA is not based on single criteria but on constellation of
findings, in particular, papillary projecting into open spaces as well as clear nuclei with
prominent nuclear groove and psammoma bodies. It is increasingly recognized that
carcinoma partially or completely composed of follicles but having nuclear features
characteristics of papillary carcinoma behave biologically as papillary carcinoma. They
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usually have favourable prognosis and a propensity for lymph node metastasis than
haematogenous dissemination as follicular carcinoma do. These carcinoma are now
diagnosed as papillary carcinoma, and those with exclusive or near-exclusive follicular
component are designated follicular variants of papillary carcinoma. Majority of papillary
carcinoma have some follicular component.
Sub types of papillary carcinoma worthy of special mention include - Insular variant
is a poorly differentiated tumor composed of solid clusters or nests of cells often containing
microfollicles and has prognosis intermediate between typical anaplastic carcinoma and
differentiated carcinoma .
Encapsulated papillary carcinoma are surrounded by thick or thin fibrous capsule and
comprise 4- 14% of papillary carcinoma. They have much better prognosis than those with
infiltrating margins.
The tall cell variant of papillary carcinoma is characterized by elongated tall cells
with basally oriented nuclei. These have worse prognosis than usual papillary carcinoma,
with higher incidence of extra thyroidal invasion, recurrence, distant metastasis and death.
The diffuse sclerosing variant of papillary carcinoma is also more aggressive. It
diffusely involve one or both lobes and is associated with extensive sclerosis, numerous
bodies, a focally solid pattern, and a lymphocytic infiltrate. Lymph node metastasis are
present in most cases and pulmonary metastasis often occur.
Cervical lymph node metastasis are present in 37-54% of patients with papillary
carcinoma. Indeed lymph node metastasis are found more frequently with small tumors
probably as a reflection of patient presentation, lymph node involvement may overshadow
the primary especially if it is microscopic size. Lymph node involved may be totally replaced
by thyroid tissue, a circumstance which was earlier designated as replaced aberrant thyroid.
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Nodal metastasis are more frequent in young. There is no difference in survival between
patient regional nodes are uncommon and occur in 12-14% of papillary Carcinoma.
Metastasis are usually to lung, mediastinum and less often to bone, brain. Reported mortality
varies from 2 -11 %. The most important factors associated with poor outcome are patient
age over 50 yrs at diagnosis, extra thyroidal extension, tumor size greater than 1.5cm, angio-
invasion, male sex and possibly DNA aneuploidy. Relative proportion of papillary and
follicular components, presence of squamous metaplasia, psomomma bodies and fibrosis do
not correlate with prognosis.
ii) Follicular carcinoma:
It is the next most common thyroid carcinoma comprising 20-25%, incidence is less
in iodine sufficient areas. They occur more commonly in women (F:M= 2.6:1), most often in
middle aged or older individual. They tend to behave more aggressively than papillary
carcinoma and have a lower survival rate. While lymph node metastasis are unusual, a
significant number of patients initially present with or subsequently develop distant
metastasis.
Gross: Follicular carcinoma are solid, fleshy tumor that unlike papillary carcinoma
are rarely occult, larger tumor may have focal haemorrhage or necrosis.
Micro: Follicular carcinoma have a range of pattern similar to those found in
follicular adenomas. They may be solid with little actual follicle formation, form trabeculae
or cords or have micro follicles. The architectural pattern has no pleomorphic and usually do
not show a marked increase in mitotic activity, multicentricity is much less common than
papillary carcinoma. Follicular carcinoma have been divided into:
- encapsulated or minimally invasive carcinoma
- widely invasive carcinoma
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Minimally invasive carcinoma are grossly and microscopically encapsulated and thus
follicular adenoma. Grossly they are not as colloid rich as adenomatous nodules and some
follicular adenomas. They are distinguished from follicular adenomas by presence of
microscopic capsular or blood vessel invasion. It is generally agreed that cytologic atypia and
increased mitotic activity in an encapsulated follicular neoplasm should not be used as basis
for diagnosis of carcinoma in absence of capsular or vascular invasion. Capsular or blood
vessel invasion is usually focal, and many sections are needed to be examined before this is
demonstrated.
Widely invasiave carcinoma include non-encapsulated carcinoma and
encapsulatedcarcinoma with marked vascular and thyroid invasion, which may be
microscopically apparent.
Definition of capsular invasion varies among authors. Kahn and Perzin defined
capsular invasion as presence of tumor in capsule beyond the main tumor mass. Evans
defined it as tumor nests within capsule. While tumor nests within capsule might represent
invasion, it could also represent entrapment within capsule of adenoma. Therefore, growth of
tumor cells into capsule roughly perpendicular to main tumor mass is necessary to diagnose
as capsular invasion.
The definition of blood vessel invasion also varies among authors. It is generally
agreed that vessels should be in the capsule or outside the capsule rather than in the tumor
itself, that the vessels should be of venous caliber and tumor thrombus should he attached to
vessel wall or covered by endothelium.
The prognosis of patient with encapsulated minimally invasive carcinoma is much
better than for those with widely invasive carcinoma.it is found that metastasis developed in
2-3% and 25% of patient with minimally and widely invasive carcinoma respectively and
cumulative death rate at 10 years was 3% and 32% respectively. Other unfavorable
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prognostic factor include age >50 years at diagnosis, size more than 4 cm extra thyroidal
invasion and to less extent histologic differentiation. Presence of metastasis at time of
diagnosis appears to be most un-favorable risk factor.
Unlike papillary carcinoma, regional lymph node metastasis are unusual and distant
metastasis are much more common usually to be bone, lungs via hematogenous route. Metastasis
and recurrence may be cytologically bland, even resembling normal thyroid, and may be
histologically diagnosable as malignant  only because of their location.
b) Poorly differentiated carcinoma:
i) Hurthle cell carcinoma: Hurthle cell carcinoma accounts for 3% of allthyroid
malignancies is a subtype of follicular carcinoma that closely resembles follicular carcinoma.
This occurs in older persons usually 60-70years of age. The tumor contains an abundance of
oxyphilic cells or oncocytes. They differ from follicular carcinoma in that they are more
often multifocal and bilateral (approximately 30%),usually do not take up RAI are more
likely to metastasize to local nodes (25%) and distant sites and are  associated with high,
mortality rate.
Gross: The tumors are characteristically solid and well vascularized. Most are well
encapsulated throughout, invasive tumors tend to grow into the parenchyma in a
multinodular fashion than can be very deceptive in that it can be underinterpreted as nodular
hyperplasia.
Micro: The pattern of growth  may be follicular, trabecular or papillary. The former is
most common. The follicles when large are separated by long and thin fibrovascular septa
that stimulate papillae when cut tangentially
50
iii) Medullary carcinoma;
medullary carcinoma accounts for 5% to10% of thyroid malignancies.The
malignancy  involves the para follicular cells   or c  cells  derived from neural crest cells. this
can occur in  sporadic cases   as a part of  MEN  type 2A  or 2B . sporadic cases are  more
common in  women   while familial cases are autosomal dominant and affect both sexes
equally. In sporadic cases, the lesion usually within one lobe where as men involves upper
halves of both lobes.
Medullary thyroid tumors secrete not only calcitonin and carcino-embryonic antigen
(CEA) but also calcitonin gene related peptide (CGRP), histaminadases, prostaglandins E2
and F2a and serotonin. The calcitonin excess is not associated with hypocalcemia. The
presence of both a mass and an elevated calcitonin level is diagnostic of medullary
carcinoma. Calcitonin is more sensitive tumor marker but CEA is a better predictor of
prognosis. Screening for pheochromocytoma with 24 hour urinary catecholamines is
mandatory in any patient whose thyroid mass is suspected as being medullary thyroid
carcinoma.
Medullary carcinoma invades locally and gives rise to metastsis in cervical and
mediastinal lymph nodes(50%) and also in distant organs (15-25%) particularly in lung, liver
and skeletal system.
Gross: The tumour is solid, firm and non-encapsulated but relatively well
circumscribed and has a grey to yellowish cut surface.
Micro: The classic presentation is represented by a solid proliferation of round to
polygonal cells of granular amphophilic cytoplasm and medium sized nucleus, separated by a
highly vascular stroma, hyalinized collagen and amyloid. The nuclei resemble those of
neuroendocrine tumours in other areas of body. They are usually round and stippled “pepper
and salt” chromatin.
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There are several historical variants which include
a. Enacapsulated - better prognosis.
b. Follicullar.
c. Papillary.
d. Small cell- worst prognosis.
e. Giant cell.
f. Clear cell .
g. Melanontic .
h. Oncocytic.
i. Squanous .
j. Amphicrine.
k. Paraganglioma like
Age <40yrs, female sex, association with MEN 2a, uniform cytology, abundant
amyloid and tumor confined to the thyroid are pointers to favourable outcome, while
association with MEN 2b, necrosis with in tumor and high mitotic activity are adverse
features.
d) Anaplastic carcinoma:
Anaplastic thyroid carcinoma represent less than 1% of all thyroid malignancies. This
occurs in 7th or 8th decade. It is most aggressive from with dysphagia, cervical tenderness
and painful neck mass. Superior venacava syndrome can also be part of presentation regional
lymph nodes are frequently enlarged. Distant metastases to lungs and bones are not
uncommon
Gross: the tumour is bulky, locally invasive, with a firm, whitish apperrance withextensive
intrathyroidal extension.
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Micro: These carcinomas are poorly differentiated with varying combinations ofgiant cells,
spindle cells, squamous cells and fibrosis. Mitotic figures are abundant as are necrosis and
vascular invasion.
Lymphomas:
Lymphomas account for less than 1% of thyroid malignancies and most are of the
non-B-cell type.
Secondaries in thyroid: can occur from
- Renal cell carcinoma
- malignant melanoma
- Bronchogenic carcinoma;
- Breast carcinoma
These are rare very in thyroid.
Thyroid cyst :
common cause colloid degeneration   ,50%  .there  will be absence of epithelial
lining.  involution of follicular adenoma present like a  cyst.30% of solid nodules are
cystic.cyst formation is common  in papillary carcinoma of thyroid surgery indicated in
complex cyst and if the size of the cyst more than 4cm Aspiration yields  altered blood but
re-accumulation is frequent.
v) Thyroiditis:
Types of thyroiditis:
1. Chronic lymphocytic thyroiditis (Hashimoto thyroiditis).
2. Sub-acute lymphocytic thyroiditis or sporadic or silent thyroiditis or post-
partum thyroiditis.
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3. Sub acute granulomatous thyroiditis (de-Quervain’s thyroiditis).
4. Acute suppurative thyroiditis.
5. Invasive fibrous thyroiditis(Riedel’s thyroiditis).
1) Hashimoto ’s thyroiditis :
This is clearly autoimmune in nature and may be the mostcommon autoimmune
disorder as well. The disorder occurs as a painless diffuse goiter in young or middle aged
women (30-50yrs). The hallmarks of this disorder are high circulating antibodies to thyroid
peroxidase (thyroid microsomal antigen) 90%, thyroglobulin, antibodies against TSH
receptors. Progressive immunologically mediated thyroid cell damage leads to goiter
formation and thyroid gland failure. Euthyroid individuals with Hashimoto ’s thyroiditis
develop hypothyroidism at the rate of approximately 5% per year. Mild thyrotoxicosis
(Hashitoxicosis) has been reported to be the initial manifestation in up to 5% of patients.
Physical examination typically reveals, non-tender goiter, which is generally symmetrical,
often with a palpable pyramidal lobe. Regional lymph node enlargement may be observed.
Nodular thyroid disease frequently occurs in Hashimoto’s thyroiditis.
Gross: The cut surface is friable, vaguely or distinctly nodular, yellowish gray andgreatly
resembles a hyper plastic lymph node. Colloid is not clearly discernible. Necrosis and
calcification are absent.
Micro: There is disruption of epithelial cells and remaning epithelial cell and
remaningepithelial cell become large and show oxyphilic changes (Askanazy cells or Hurthle
cells). Two main abnormalities are lymphocytic infiltration of the stroma and oxyphilic
change of follicular epithelium. The lymphoid tissue is distributed within and around the
lobes and it exhibits large follicles with prominent germinal center. Plasma cells, histiocytes
and scattered intra-follicular multinucleated giant cells can be present.
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2) Sub-acute granulomatous thyroiditis :
This disorder has a number of eponyms including de Quervain’s thyroiditis, giant
cell thyroiditis, and sub-acute painful thyroiditis. This occurs more commonly in 30 to 40
years old women. A virus (Mumpsvirus and an unidentified cytopathic virus) etiology has
been implicated. This often follows an upper respiratory tract infection. The symptoms
includes painful thyroid enlargement, pain radiating to patient’s jaw, muscular aches, fatigue,
fever and malaise. Sub-acute thyroiditis has been associated with adeno, Coxsackie,
Epastein-Barr and influenza viral infections and has been reported after hepatitis B
vaccination.
The acute phase consists of thyrotoxicosis caused by follicular destruction and
leakage of preformed hormone from the gland lasts 3 to 6 weeks but may last longer. During
this phase the erythrocyte sedimentation rate is marked elevated. The radioactive iodine
uptake during the thyrotoxic phase is low. After the acute phase, a period of transient
asymptomatic euthyroidism follows. Hypothyroidism may occur after several more weeks
and may last for several months, the recovery phase follows when all aspects of thyroid
function return to normal in 4 to 6 months. Hypothyroidism may be permanent in up to 5%of
patients.
Gross: The gland is enlarged twice it’s normal. In advanced stage, the involved areas
are firm.
Micro: The  areas of marked inflammation and granulomas containing foreign body
giant cells are present. The granulomas are not very distinct and caseation necrosis is
consistently absent. Areas of fibrosis are seen, usually in patchy distribution.
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3) Acute suppurative thyroiditis:
Bacterial infections of thyroid are rare. It is more common in children and is often
preceded by upper respiratory tract infection or otitis media. The resistance of the thyroid due
to infection is due to protective mechanisms that include is (1) rich blood supply to and
lymphatic drainage from the thyroid, (2) the high glandular content of iodine which may be
bactericidal, (3) the separation of thyroid from other structures of the neck by fascial plane
and complete protective fibrous capsule surrounding the gland. The most common
predisposing factor to infections of the gland appears  to  be  preexisting  thyroid  disease
since  simple  goiter, nodular  goiter, Hashimoto’s thyroiditis or thyroid carcinoma
has been observed in up to two thirds of women and half men with infections thyroiditis.
Bacterial infections (Staphylococcus aureus and streptococcus pyogenes) are the most
common cause of infectious thyroiditis . Bacterial thyroiditis may occur either via spread
from a distant focus through the bloodstream or lymphatic or by direct inoculation from
contiguous focus.
4) Riedel’s thyroiditis :
Riedel’s thyroiditis, also known as Riedel’s struma and invasive fibrous thyroiditis, is
a rare disorder of unknown etiology that is characterized by extensive fibrosis of thyroid
gland this affects mainly women between the ages of 30 to 60 yrs (F:M= 3 to 4:1) thyroid
antibodies have been reported in up to 67% of painless goiter. The extensive fibrosis is
progressive and may eventually cause compression of adjacent structures particularly to
trachea and oesophagus.
Physical examination reveals a goiter often described as “woody ” in texture . Most
patients are euthyroid unless almost complete replacement of gland occurs resulting in
hypothyroidism.
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Gross : The gland the is asymmetrical and involves only localized areas of the thyroid
gland. The affected portion is stony hard and cuts with great resistance. Dense fibrous tracts
extend from thyroid capsule to adjacent muscle, so that at surgery, the tissue planes are
obliterated.
Micro: Fibrous tissue, that is frequently extensively hyalinized completely replaces
the area, is often directly infiltrated by this connective tissue. Gaint cells are absent. The
inflammation present is patchy and mononuclear type, with a predominance of lymphocytes
and plasma cells.
TNM Classification of Thyroid Tumors
Papillary or Follicular Tumors
Stage TNM
<45 y
I Any T, any N, M0
II Any T, any N, M1
≥45 y
I T1, N0, M0
II T2, N0, M0
III T3, N0, M0; T1–3, N1a, M0
IVA T4a, N0–1a, M0; T1–4a, N1b, M0
IVB T4b, any N, M0
IVC Any T, any N, M1
Medullary Thyroid Cancer
Stage TNM
I T1, N0, M0
II T2–3, N0, M0
III T1–3, N1a, M0
IVA T4a, N0–1a, M0; T1–4a, N1b, M0
IVB T4b, any N, M0
IVC Any T, any N, M1
Anaplastic Cancer
Stage TNM
IVA T4a, Any N, M0
IVB T4b, Any N, M0
IVC Any T, Any M, M1
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Definitions:
Primary tumor (T)
TX = Primary tumor cannot be assessed
T0 = No evidence of primary tumor
T1 = Tumor ≤2 cm in diameter, limited to thyroid
T2 = Tumor >2 cm but <4 cm in diameter, limited to thyroid
T3 = Tumor >4 cm in diameter, limited to thyroid, or any tumor with
minimal extrathyroidal invasion
T4a = Any size tumor extending beyond capsule to invade subcutaneous soft
tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve, or
intrathyroidal anaplastic cancer
T4b = Tumor invading prevertebral fascia, or encasing carotid artery or
mediastinal vessels; or extrathyroidal anaplastic cancer Regional
lymph nodes (N)—include central, lateral cervical, and upper
mediastinal nodes
NX = Regional lymph nodes cannot be assessed
N0 = No regional lymph node metastasis
N1 = Regional lymph node metastasis
N1a = Metastases to level VI (pretracheal, paratracheal, and
prelaryngeal/Delphian lymph nodes)
N1b = Metastases to unilateral, bilateral, or contralateral cervical or
Superior mediastinal lymph nodes
Distant metastasis (M)
MX = Distant metastases cannot be assessed
M1 = No distant metastasis
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CLINICAL FEATURES
HISTORY:
1) Swelling :
Most commonly patients present with a history of a slowly growing swelling which
otherwise is asymptomatic. Sudden increase in size is suggestive of haemorrhage into the
nodule. Recent increase in size is suggestive of malignancy.
2) Pain:
Some patients complain of vague pain in the nodule. Recent onset of sudden pain
suggests haemorrhage into the nodule. Pain is also feature in Riedel ‘s thyroiditis. Pain is a
late feature of malignancy which has invaded deeper structures.
3) Pressure symptoms:
a. History of hoarseness of voice, not due to upper respiratory disease, suggests
malignant nature of the nodule because of malignant infiltration of recurrent laryngeal
nerves. Rarely, a benign large nodule can press upon the recurrent laryngeal nerve leading to
hoarseness of voice.
b. Pressure upon the trachea causes dyspnoea and on the oesophagus may cause
dysphagia.
4) Symptoms of toxicity / hypothyroidism:
Toxic symptoms are seen in toxic adenoma, toxic adenomatous nodule and very
rarely in functioning carcinoma. Symptoms common to most patients with hyperthyroidism
include heat intolerance, increased sweating and thirst, and weight loss despite adequate
caloric intake. Symptoms of increased adrenergic stimulation include palpitations,
nervousness, fatigue, emotional lability, hyperkinesis, and tremors. The most common
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gastrointestinal symptoms include increased frequency of bowel movements and diarrhea.
Female patients often develop amenorrhea, decreased fertility, and an increased incidence of
miscarriages.
The symptoms hypothyroidism. in general, are non-specific, they include tiredness,
weight gain, cold intolerance, constipation, and menorrhagia. Patients with severe
hypothyroidism or myxedema develop characteristic facial features as a consequence of the
deposition of glycosaminoglycans in the subcutaneous tissues, leading to facial and
periorbital puffiness. The skin becomes rough and dry often develops a yellowish hue from
reduced conversion of carotene to vitamin A. hair becomes dry and brittle, and severe hair
loss may occur .there is also a characteristic loss of the outer two-thirds of eyebrows. An
enlarged tongue may impair speech, which is already slowed, in keeping with the impairment
of mental processes. Untreated dementia may lead to myxedema madness. Patients may also
have nonspecific abdominal pain accompanied by distention and constipation. Libido and
fertility are impaired in both sexes.
5) Symptoms of metastasis:
In bones, lungs etc. may be seen in follicular, anaplastic and rarely papillary
carcinoma. Lymph node metastasis may present as lateral neck swellings along with or
thyroid swelling.
6) Diarrhea may be only symptom of medullary thyroid carcinoma
Family history :
Family history of thyroid swelling is usually seen in familial medullary thyroid
carcinoma.
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Past history:
Past history of neck irradiation is significant as it may lead to papillary carcinoma of
thyroid.
PHYSICAL FINDINGS :
General physical examination helps to assess whether the patient is euthyroid,
hypothyroid or hyperthyroid. It may reveal a metastatic site from a cancerous nodule of
thyroid.
Patients with hyperthyroidism, on physical examination
 will have weight loss and facial flushing
 skin may be warm and moist and, African American patients often note
darkening of their skin
 Tachycardia or atrial fibrillation is present, with cutaneous vasodilation leading to a
widening of the plus pressure and a rapid fall off in the transmitted pulse wave
(collapsing pulse), congestive cardiac failure may also be present
 A fine tremor, muscle wasting, and proximal muscle group weakness with
hyperactive tendon reflexes are often present.
Patients with severe hypothyroidism or myxedema develop characteristic facial features as a
consequence of the deposition of glycosaminoglycans in the subcutaneous tissues, leading to
facial and peri-orbital puffiness skin becomes rough and dry and often develops a yellowish
hue from reduced conversion of carotene to vitamin A
Hair becomes dry and brittle, and severe hair loss may occur
There also is a characteristic loss of the outer two-thirds of the eyebrows
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Cardiovascular changes in hypothyroidism include bradycardia, cardiomegaly,
pericardial effusion, reduced cardiac output, and pulmonary effusions. cardiac failure is
common.
Generally, a solitary nodule to be appereciable by hand , should be at least 1 cm In
diameter. The thyroid nodule always moves with deglutition unless it is adherent To a
neighboring tissue  by  malignant process or rarely  Reidel’s thyroiditis. The lower  border  of
the  swelling if palpable  suggests no  retrosternal extension. The consistency of the nodule is
deceptive. A cystic nodule may appear firm. A soft nodule does not rule out malignancy as
follicular carcinoma may appear soft.
A hard nodule suggests malignancy, but can also be due to calcification in an
adenomatous nodule. Cystic variety of papillary carcinoma is known to occur. Adenoma and
cystic degeneration in an adenomatus nodule can present as cysts. Mobility of the nodule if
restricted suggests malignancy.
Trachea may be deviated to opposite side by the pressure effect of nodule. Carotid
artery may be pushed laterally by benign lesions and pulsation may be absent at the level of
gland in cases of malignancy (Berry’ s sign).
Regional lymph nodes i.e. pretracheal, paratrachal, lower deep cervical and
sometimes upper deep cervical may be enlarged and palpable, due to metastases from
papillary carcinoma of thyroid. Cystic degeneration may also occur in these lymph nodes.
Thus by clinical examination it is difficult to find out the aetiology of solitary nodule.
It is impossible to make a diagnois of malignant nodule clinically unless certain features of
malignancy are obvious such as:
1. Hoarseness of voice
2. Cervical lymphadenopathy
3. Distant metastasis
4. Hard consistency
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5. Fixity of nodule
6. Berry’s sign
Absence of the features by no means rules out the possibility of malignancy, thus, making the
solitary nodule  clinically nodule clinically problematic.
WORK PLAN FOR SOLITARY NODULAR GOITRE
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INVESTIGATIONS
ROUTINE INVESTIGATIONS:
As in other general surgical cases, routine investigations like blood analysis (Hb%,
BT, CT), urine analysis, radiological assessment of chest are done to assess the fitness of the
patient to undergo major surgical procedure.
SUPPORTIVE INVESTIGATIONS :
1) Sleeping pulse rate: To differentiate tachycardia due to anxiety from that of
thvrotoxicosis, pulse rate is counted when the patient is asleep. A count of more than
90/min is suggestive of hyperthyroidism. A rate of 90-100/min indicates mild, 100-
110/min moderate and more than 110/min severe hyperthyroidism.
2) ECG: In hypothyroid state, low voltage, flattened ST wave or inversion of T waves
are seen. In hyperthyroidism sinus tachycardia, atrial tachycardia, atrial fibrillation
and signs of left ventricular hypertrophy may be seen.
3) Serum cholesterol: In hypothyroidism, it is markedly increased (more than 300mg%).
4) Serum creatinine: Raised serum creatinine in presence of toxic features confirms
thyrotoxicosis even though BMR is normal. In all, muscle wasting disorder should be
ruled out.
5) Indirect laryngoscopy: Routine laryngoscopic examination should be made before
thyroidectomy.3-5% of the patients have paresis or paralysis of one vocal cord
probably due to exanthemata during childwood. Pre-operative detections of vocal
cord paralysis protects the surgeon from possible litigation. It also helpful in
diagnosing involvement of recurrent laryngeal nerve.
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6) Radiological investigation:
Radiography of neck : It is helpful in determining the position of trachea, retrosternal
extension and also calcification in the nodule. Calcification is seen in long standing
adenomatous goiter and papillary carcinoma and extensive calcification in nodular
goiter.
7) Basal metabolic rate (BMR): BMR measures oxygen consumption per minute. In
hyperthyroid patients BMR will be raised. Non specificity of the test, lead to its
almost disappearance from the scene in the diagnosis of hyperthyroidism.
8) SPECIFIC INVESTIGATIONS :
i) Tests for thyroid function :
Most of the patients with solitary thyroid nodule are euthyroid, but laboratory
confirmation of this is generally agreed that no single procedure, consistently yields
reliable basis for diagnosis and therefore, a combination of various tests are generally
required.
Total thyroid hormones:The most useful index of thyroid function is the
directmeasurement of circulating thyroid hormones. Total T4 and total T3 are
designated T4 and T3 respectively. These are measured by radioimmune assays.
Normal values :
T4 : 55-155 nmol/lit.
T3 : 1-3 nmol/lit.
The commonest fallacy of estimation is, it measures total T4 and fails to detect
thyroid binding globulin only. It is necessary to have information of binding protein
to interpret T4 and T3 values. Factors that increase thyroxine binding globulin (TBG)
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concentration (estrogens, pregnancy, liver disease) may elevate T4 and T3, decrease
in globulin occurs. In nephriticsyndrome, Patients on androgens,glucocorticosteroids,
hypoproteinemia, cirrhosis and acromegaly. In many centers, the use of T3 resin
binding test is still as an indirect measurement of circulating thyroid hormone.
ii) Tests for thyroid binding proteins:
This test measures unoccupied thyroid hormone binding sites on TBG. This is done
by using T3 resin uptake test (T3 RU). Radioactive T3 is inoculated with the patients serum,
so that it becomes fixed to any thyroid binding protein not already carrying T3 or T4. The
amount so fixed can be measured and from this can be estimated the number of binding sites
in the serum which are un-occupied . In hyperthyrodism, the number of free binding sites of
TBG is low because most of them are already carrying hormone, where as in hypothyroidism
the number of free sites are high. Now -a-days using sephandex or thyopac method and
taking 100% as the mean normal value for free binding sites, a figure of 85% or less suggest
hyperthyroidism and a figure of 120% or more suggest hypothyroidism.
iii) Thyroid hormone indices (by calculation):
Free throxine (FTI)(FT4I) can be calculated as FTI = serum T4 x T3 uptake percent
(T3RU). Similarly free T3 (Ft3I) can also be calculated. FT4I in euthyroid patients is 0.85 to
3.50 and that of FT3I is 1.4-3.7. It is probably the best parameter of thyroid function at the
present moment.
iv) Free thyroid hormone measurements:
Ft4 can be measured by two methods: equilibrium dialysis or radio immunoassay
(RIA). Dialysis methods is the gold standard, however, is restricted to research laboratories
as it is time consuming and only a small number of samples can be processed.
Simultaneously ft4 measurements by RIA is valuable and it provides an excellent index of
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thyroid status in almost any clinical situations. Normal ft3 is 1.3-3.5 nmol/l and ft4 is 170-
160 nmol/l (12-28 pmol/l).
v) Serum thyroid stimulating hormone (TSH):
Another very sensitive test of thyroid function is the serum TSH value. This is
measured by immunoassay technique. The normal serum TSH level is 0.3-5miu/l. It is raised
in primary hypothyroidism (may be over 40 miu/l) and almost undetectable in
hypothyroidism. It is the most sensitive test of primary hypothyroidism.
vi) Tests of hypothalamic-pituitary axis of TRH test:
Thyrotropin releasing hormone (TRH) is produced in para-ventricular nucleus of
hypothalamus and passes through the median eminence of anterior pituitary via the
hypophyseal portal system. When TRH, a hypothalamic releasing factor is given
intravenously in a dose of 200 pg to a normal individual, the level of TSH in the serum raises
from the basal level of about 1µu/ml at 20 minutes and returns to normal by 120 minutes.
This is a time consuming test and only occasionally gives information not obtained from
routine tests of thyroid function.
vii) Radioiodne uptake (RAIU)test:
Routine isotope scanning has been abandoned except when toxicity is associated with
nodularity.
viii) Thyroid scintigraphy : The use of radionuclide agents has been helpful in
delineatingthe presence, size, and function of thyroid nodules. Two radioactive iodine
isotopes have been employed, in clinical use, scanning with 123I (dose of 1-2 Ci) has its
advantage of low dose radiation (30 m rad) and short half- life (12-14 hours). This compares
favourable with the use of 131I (dose of 5 mCi) which has a higher dose of radiation (500 m
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rad ) and longer half-life (8 to 10 days). Scanning with 123I is usually used for Patients with
differentiated thyroid carcinoma to screen for distant metastasis. The best radionuclide is 123
I but now most of them are preferring 1-2 mCi of 99m Tc pertechnate (half-life 6 hours)
given by IV injection and image after 5-10 min. 123I  is  trapped  and  bound  tothyroglobulin
by  the  thyroid follicular cells, whereas 99m Tc is only trapped but not organified. Screening
with 99m Tc also shows  uptake  in  salivary  glands  and  major vascular structures and
therefore requires high sophistication of interpretation. 99Tc pertechnate is preferred for
imaging agent when:
a. Patient is taking thyroid blocking agents
b. Patients is unable to take medication orally.
c. The study must be completed less than 2 hours
d. Thyroid function (uptake measurement) is not necessary.
Indication for thyroid scan :
1. Determine the size of thyroid
2. Depending on the ability to take up isotope than the surroundings, nodules
are divided into:
a . Hot nodule (hyperfunctioning) (5%). The incidence of malignancy is 4%.
b. Warm or neutral nodule (10-15%). The incidence of malignancy in 9%.
c. Cold nodule (hypo functioning) (80-85%). The incidence of malignancy is 15-20%.
3. Determining the retrosternal shadow on chest x-ray is a thyroid.
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4. Differentiate between an autonomously functioning nodule from an hyperactive
multi-nodular gland with a dominant nodule.
5. Post operatively to assess the residual thyroid tissue left behind after total
thyroidectomy and whole body scintigraphy to detect secondaries from differentiated
thyroid carcinoma.
Limitations of radionuclide scan :
1. It cannot differentiate benign from malignant nodule, other pathological conditions
which produce cold nodule include adenoma, adenomatous hyperplasia, colloid cyst,
haemorrhagic cyst, Hashimoto’s thyroiditis, sub-acute thyroiditis and a large
parathyroid adenoma or cyst
2. Inadequate visualization of the nodules at the periphery, isthmus and cold nodules
surrounded by normal thyroid tissue . Nodules <1 cm are usually not visualized as
radioactivity form normal gland passes through it. This can be overcome by oblique
and /or lateral images.
3. Certain artifacts such as an asymmetric of a lobe or a tortuous carotid artery may
distort a normal gland thus producing an abnormal scan.
Following high dose of 131I administration, patients are hospitalized in isolation until
the retained radioactivity is less than 15 mCi or the radiation exposure rate from the patient is
less than 2.5 Mr/hr at l meter. Other radionuclides utilized are Gallium 205, 99mTc
pentavalent dimercatposuccinate (DMSA).
ix) Ultrasonography :  Ultrasound is a simple, rapid, relatively cheap and noninvasive
method to study the structure of thyroid. High  resolution ultrasonography (7.5 to 10 MHz)
is sensitive  in identifying impalpable  nodules as small as  0.3 cm in diameter. USG is useful
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in distinguishing between solid and cystic lesions, they are rarely malignancy and mixed
solid- Cystic lesions has a 5% risk of malignant. Cysts seen in USG, those larger than 3cm
are malignant in 14% of cases. Currently USG is used in obtaining the accurate measurement
of size of the nodule in a patient who is put on suppressive therapy, and guide FNAC of
complex cystic lesion  nodule that  is situated posteriorly and to access cervical
lvmphadenopthy. Benign lesion nodule shows “hallow sign ” on USG and features
suggestive of malignancy include hyperchoic pattern in complete peripheral halo, irregular
margins and microcalcifications.
x) Computerized tomography and magnetic resonance imaging :
There is no place for CT scanning and MRI in routine evaluation except to determine
the extent of a large cervical or retrosternal thyroid and spinal metastases
xi) Tissue diagnosis :
a) fine needle aspiration cytology (FNAC):
The wide spread use of FNAC in diagnostic assessment has led to an increased
incidence of malignancy with a concomitant reduction in cases requiring thyroid surgery
producing a favorable cost reduction. FNAC is, therefore, a highly accurate and cost effective
diagnostic technique of low morbidity providing a valuable to clinical assessment in overall
selection of patients with thyroid nodules for surgery. The sensitivity of FNAC for detection
of malignant lesions is approximately 83% and the specificity is about 92%. Problems with
FNAC include difficulty in differentiating follicular adenoma from carcinoma.
Pit falls in FNAC of thyroid as mentioned by Shaha.
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 adequacy of specimen (quantitative  and qualitative).
 adequacy of specimen (no homogenicity of needle placement0.
 accuracy of cytopathologic interpretation.
 cysts (difficulties with degenarate nodules).
 Follicular lesions (benign Vs malignant).
 Hurthle cell lessions (benign Vs malignant).
 Lymphocytic  lesions ( lymphocytic thyroiditis Vs lymphoma)
b) Core needle biopsy :
This is done under local anaesthesia, is occasionally of value in establishing
diagnosis  in  a patient  with  a patient with a large often hard and fixed mass in the neck
frequently on the basis of anaplastic carcinoma or thyroid lymphoma.  Core biopsy produces
a small cylinder of tissue which is subjected to histopathological examination. Because of the
caliber of the needle and the consequent haemorrhage, haematoma, injury of trachea and
damage to RLN, there is no place for large needle biopsy of this type in the routine
evaluation of solitary nodule thyroid.
xii) Serum Thyroglobulin (Tg) :
Normal levels 1-43 ng/ml. Tg may be elevated in patient with follicular or papillary
carcinoma. However, its usefulness in preoperative evaluation lacks specificity, because Tg
concentration is also elevated in thyroiditis, follicular adenoma, MNG. It is useful in post-
operative period after total thyroidectomy for long term follow up in whom a marked rise
may herald recurrence. It is especially helpful in cases where metastasis fail to concentrate
RAI. Tg levels do not always correlate with extent of recurrence or metastatic disease. After
total thyroidectomy during follow up if Tg>10 ng/ml, it indicates recurrences or metastasis.
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xiii) Serum Calcitonin:
Calcitonin hormone secreted by para-follicular C-cells serves as useful marker in
detection and follow up of medullary carcinoma. Elevated serum calcitonin in a patient with
thyroid mass is virtually diagnostic of medullary carcinoma. Occasionally patient with these
tumor and many with familial C-Cell hyperpasia have normal baseline level. They
demonstrate rise in calcitonin concentration following provocative calcium infusion or
pentagastrin stimulation
xiv) Measurement of antibobies :
About 95% of patients with Hashimoto’s thyroiditis and 80% with Grave’s disease
have detectable anti-microsomal antibodies. Anti-microsomal antibodies are found in with
Hashimoto’s, Anti-TSH antibodies are detectable in patients with autoimmune
hyperthyroidism ( Grave’s disease )
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TREATMENT
The  common indications for surgery in a solitary nodule are as follows :
1) Pressure effects, irrespective of aetiological diagnosis .
2) Malignancy.
3) Cosmesis .
The  treatment for different aetiological entities can summarized as follows:
1] Adenomatous non–toxic nodules
As the basic cause is diminished synthesis of thyroxine in the body the entity should
be treated by thyroxine replacement therapy (0.1- 0.2 mg /day) preferably
serum levels of T3, T4 and TSH be measured at regular intervals and level should be
monitored by adjusting the dose of oral thyroxine administration some nodules regress during
therapy. if the nodule is large causing pressure effects or if it is cosmetically not acceptable
to the patient surgery is indicated hemithyroidectomy is done. All these should be followed
up post operatively and thyroxine replacement therapy should be instituted to prevent
recurrence
2] Lymphocytic thyroiditis :
It eventually result in hypothyropidsm, treatment is essentially conservative
consisting of careful follow up; oral thyroxine substitution therapy by monitoring the serum
levels of T3, T4, TSH. There is no scope for surgery except for pressure effects by a large
nodule or for cosmesis
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3) Toxic nodule:
It is an autonomously functioning thyroid nodule that produces hyperthyroidism.
Toxic nodule can be treated by surgery or radioactive iodine therapy. Radioiodine is the
treatment of choice over the age of 45 years, as toxic nodules are rarely malignant, provided
all the following criteria are satisfied.
- patient should have completed family (either postmenopausal or sterilized).
- There should be no pressure effects
- Cosmetically, these nodules should be  acceptable as the size  of the nodule
may not regress with radioiodine.
If  any  of  the  above  mentioned  criteria  is  not  satisfied,  surgery  is indicated.
Treament is by hemithyroidectomy since the  rest of the gland is suppressed by toxic nodule,
post -operative hypothyrodism rarely occurs.
4 ) Thyroid cyst :
About 15% of all thyroid nodules are cystic. Majority of them (97%) are benign. Very
rarely,  papillary  carcinoma  can  present  as  cyst  due  to degeneration.
All thyroid cysts initially treated by simple aspiration by a needle and centrifuged Aspirate
sent for cytopathology.  After  aspiration,  the  thyroid is palpated and if There is any solid
remnant, aspiration, aspiration biopsy of cyst wall is done to Rule out malignancy. Simple
thyroid cysts  resolve  with  aspiration  in approximately 75% of cases, although some
require second or third aspiration. If the cyst persists after 3 Attempts at aspiration, surgery is
recommended. Surgery is also recommended for cysts greater than 4 cm in diameter and for
complex cyst with sold and cystic components, because the latter have a higher incidence of
malignancy (15%)
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5) Benign neoplasms:
In the light of our present knowledge it is extremely difficult to separate benign
adenoma.A limited resection in the form of hemithyroidectomy is done. Further treatment
depends on histopathological examination. Should the report be a benign neoplasm no more
treatment is required. Should it be malignancy, it shall be treated as discussed below
6) Treatment of papillary and follicular carcinoma:
The primary treatment for papillary carcinoma is surgical excision. The extent of
resection, indication for  regional lymph node  dissection and post-operative follow up of
patients are the most controversial aspects of management. Because of slow growth  of  these
well  differentiated  neoplasms  and  the  overall  good  prognosis, recurrence of CA occur
several years after surgeryThe various treatment options are discussed as follows:
A) Surgery (Total thyroidectomy/Near total thyroidectomy):
The procedure involves removal of the entire thyroid gland with identification and
preservation of recurrent laryngeal nerves and parathyroid glands. Reasons for total
thyroidectomy.
1. Enables one to use RAI effectively to detect and treat thyroid tissue or metastatic
disease.
2. Makes  the  serum  TG  level  more  sensitive  maker  of  recurrent  or  persistent
disease.
3. Eliminates the contralateral occult cancers as sites of recurrence (because up to
85%  of tumors are multifocal).
4. Reduces the risk of recurrence and improves survival.
5. Decrease the 1 % risk of progression to undifferentiated or anaplastic thyroid cancer.
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6. Reduces the need for re-operative surgery with its attended risk of increased
complication rates.
Post-operative management:
Adjuvant therapy :
i) Suppressive therapy with thyroxine:
Post-operative thyroid hormone replacement is necessary after total or near total
thyroidectomy or ablation with radio-iodine. Thyroxine is necessary not only as replacements
therapy in patients total thyroidectomy but has additional effect of suppressing TSH and
reducing growth stimulus for any possible residual thyroid cells. TSH suppression reduces
tumor recurrence rates particularly in young patients with thyroid cancer.
Oral Levothyroxine is begun before discharge at an average dose of 100 micro
gm/day. Adequacy of thyroid hormone replacement is assessed by measuring T4 and TSH at
6 to 12 weeks after surgery. The degree to which one suppresses TSH is a point of debate. It
is advisable to keep the TSH at or below the normal range (0.5 to 5.0 microU/mL ) in
patients who are thought to be without evidence of disease and to maintain a lower TSH level
(0.1 microU/mL ) in patients with residual neck disease, metastases, or recurrent disease.
ii. Use of RAI post-operatively:
All patients who have undergone a total or near-total thyroidectomy for a papillary or
follicular carcinoma larger than 1.0 to 1.5 cm should be considered candidates for radio-
iodine ablation. 131I  ablation of any residual normal thyroid is important after what is
thought to be complete resection of the primary tumor to aid in the detection of metastatic
disease and to eradicate residual microscopic cancer.
The dose of 131I for ablation is not standardized. Some recommend low dose ablation
with less than 30 mCi given on an outpatient basis. This approach should be reserved for
76
low-risk young patients.Higher ablative doses ranging from 100 to 150 mCi should be used
for older, high-risk patients, particularly those known to have an incomplete resection of the
primary tumor, an invasive primary tumor, or metastases.
iii. Chemotherapy
The most effective non-surgical treatment for well-differentiated thyroid cancer is
ablation with radio-iodine.
Progonosis :
Most patients with papillary carcinoma can be expected an excellent prognosis, with
the 10-years survival rate approaching 95% for the most favorable stages.
Prognostic risk classification for patients with well – Differentiated thyroid cancer
(AMES or AGES)
Low risk High risk
Age < 40 years >40 years
Sex Female Male
Extent No local extension,
intrathyroidal no
capsular invasion
capsular invasion extrathyroidal
extension
Metastasis None Regional or distant
Size <2cm >4cm
Grade Well differentiated Poorly differentiated
AGES - age, pathology of tumor, extent and size of the primary tumor; AMES-age,
distant metastasis, extent of the primary tumor, and size of the primary tumor.
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MATERIALS AND METHODS
The present study on “Clinical Study of the incidence of malignant changes in
Solitary Nodule of Thyroid” has been conducted by utilizing cases admitted and managed in
the Department of Surgery at thirunelveli medical college
Prospective analysis of 50 cases of solitary nodule thyroid in the specified period
done. These cases were selected by random sampling method and studied in detail clinically
and recorded as per the proforma. Routine investigations and specific investigations
including FNAC of the nodule, Thyroid profile, IDL, Plain X-ray neck, USG neck were done
in all cases. Special investigations like radio-isotope scanning was not performed as the
facilities were not available. All the patients were managed by surgery and diagnosis was
confirmed by histo-pathological examination.
The patients were grouped according to different variables like age , sex, size of the
nodule, site of the nodule, functional thyroid status, FNAC reports and histo-pathological
examination reports, then analyzed and compared with the previous similar studies conducted
elsewhere. Finally conclusions were drawn accordingly.
Treatment :
Pre-operative :
Use of anti-thyroid drugs, beta-blockers, blood transfusions or any other medications
were prescribed based on individual status and was noted
Operative:
Position of the patient, type of anaesthesia, incision, type of operation planned, per-
operative findings and type of operation performed were recorded.
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Post-operative:
Every patient was followed up post-operatively during the course of management in
the hospital to note the development of and management of complications.
Follow-up:
At the time of discharge, all the patients were advised to attend the surgical OPD
regularly for follow up. Any recurrences or complications were noted. Thyroid functional
status was assessed, accordingly thyroxine tablets prescribed if necessary.
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RESULTS
Total of 50 cases of solitary nodule of thyroid studied and following conclusions were drawn:
Age Incidence:
The age of the patients ranges from 18 years to 66 years, with peaks being in 3rd to 5th
decades. The mean age of presentation is 37.24 years. Cases in 3rd to 5th decades constitutes
60% of the cases studied.
AGE IN NO. OF
YEARS PATIENTS
0-9 0
10-19 2
20-29 15
30-39 11
40-49 14
50-59 6
60-69 2
TOTAL 50
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Sex Incidence:
Solitary nodule of thyroid are much more common in females. Out of 50 cases
studied 46 were females and 4 were males, and the ratio comes to M : F = 1 : 11.5 . Also the
malignant nodules are common in females. Out of 6 cases of malignancy in the study, 5 were
females.
Sex no. of   patients
Males 4
Females 46
Totals 50
81
Clinical features:
All the cases in the present study presented complaint of swelling in the region of the
thyroid. Only few patients presented with pain, discomfort and dysphagia. All the mentioned
additional symptoms were of mild degree. Out of 50 cases, 3 cases had pain, 3 cases had
discomfort and another 2 had dysphagia. Also none of the patient had lymphadenopathy
which was confirmed by ultrasonographic examination. Two patients had symptoms of
thyrotoxicosis, and one had features of hypothyroidism. The latter patients’ thyroid profile
confirmed the functional status.
Duration of symptoms:
In our study, duration of onset symptoms varied from 15 days to 8 years. Also duration of
malignant nodules extend from 1 month to 4 years.
Duration of no.of patients
Symptoms
<1mon 1
1-3 mon 7
3-6 mon 10
6-12 mon 7
1-2yrs 12
2-5yrs 11
>5yrs 2
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Site of the nodule:
Out of 50 cases studied, 26 cases presented with nodule in right lobe of the thyroid gland
and the remainder in the left lobe of thyroid. One patient among left sided solitary nodule
had undergone right lobectomy 30 years back and presented with recurrent nodule in the
rest of the lobe.
site of the nodule no. of patients
Right 26
Left 24
Total 50
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Size of the nodule:
In the present study, on clinical examination size of the nodule, in its largest dimension,
varies from 2cm to 12cm. Most of the patients presented with the size of about 3 to 5 cm. in
the study, as such there is no correlation between the size of the nodule and the occurrence
malignant nodule.
Size of the No. of patients
Nodule
<1 cm 0
1-2 cm 2
2-3 cm 8
3-4 cm 15
4-5 cm 13
5-6 cm 8
6-7 cm 2
>7 cm 2
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Thyroid functional status:
Out of 50 cases, two presented with features of thyrotoxicosis, one with hypothyroidism and
rest all were in euthyroid state. Patients with thyrotoxicosis were made euthyroid using
antithyroid drugs and operated and both cases turned out to be toxi follicular adenoma.
Patient with hypothyroidism was treated with thyroxine, USG neck revealed multiple
nodules and managed by subtotal thyroidectomy, histopathological examination confirmed
the diagnosis of multi-nodular goiter.
thyroid No. of patients
functional status
Euthyroid 47
Hyperthyroid 2
Hypothyroid 1
Total 50
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FNAC Reports:
Fine Needle Aspiration Cytology is the important investigation in the evaluation of solitary
nodule of thyroid. All 50 cases were subjected to FNAC during the course of evaluation.
Fnac reports are mainly categorized into 6 entities- Benign, follicular neoplasm,
suspicious(of malignancy), malignant, lymphocytic thyroiditis, cysts. In our study, out of 11
follicular neoplasms, two turned out to be follicular carcinoma. One suspicious (of papillary
carcinoma) case confirmed papillary carcinoma on histopathological examination. Three
cases of papillary carcinoma were diagnosed pre-operatively by FNAC alone.
Two cases diagnosed as cysts by FNAC confirmed to be simple cysts on
histopathological examination.
FNAC reports No. of patients
Benign 32
Follicular 11
Neoplasm
Suspicious 1
Malignant 3
Lymphocytic 1
Thyroiditis
Cysts 2
Total 50
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Aetiological incidence of solitary nodule of thyroid:
Out of 50 cases studied, common causes of solitary nodule are MNG, follicular
adenoma and adenomatous goiter; the most common being MNG which constitutes about
36% of cases.
Follicular adenomas  have   22% and   adenomatous goiters  have 24%
incidences.
Out of 50 cases, six were malignant – 4 papillary carcinoma and 2 follicular
carcinoma.Ultrasonography detected suspicious findings in two cases among six malignant
cases – 1 papillary and 1 follicular.
Three cases of papillary carcinoma were diagnosed with certainity by FNAC, one
case was suspicious which turned out to be papillary CA on histopathological
examination.
Two cases of follicular carcinoma were diagnosed follicular neoplasm, one of
them showed suspicious features on ultrasonographic examination.
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HPE Reports No. of patients
Follicular
adenoma
11
Adenomatous
Goitre
12
MNG 18
Carcinoma 6
Lymphocytic 1
thyroiditis
Simple cyst of 2
Thyroid
Total 50
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Type of carcinoma:
From the study, out of 6 carcinoma, 4 were papillary and 2 follicular: no case of medullary
or anaplastic or lymphoma was detected. Papillary carcinoma accounts to 67% and
follicular carcinoma accounts to 33%.
carcinoma No of cases percentage
Papillary 4 67
Follicular 2 33
medullary 0 0
anaplastic 0 0
lymphoma 0 0
Total 6 100
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SURGERY / OPERATIVE PROCEDURE DONE:
Depending upon the clinical diagnosis and FNAC features, all the 50 patients
undergone surgery. Among them, 31 patients had undergone hemithyroidectomy, 12 cases
undergone sub-total thyroidectomy and 7 cases undergone total thyroidectomy.
In one case, HPE after hemithyroidectomy showed follicular carcinoma, then
completion of total thyroidectomy done. In another case with recurrent nodule
(previously hemithyroidectomy was done 30 yrs back), total thyroidectomy was done,
which showed features of MNG.
Post-operatively, suppressive dose of thyroxine was started for patients who had
undergone total thyroidectomy. Three cases out of 7 cases of total thyroidectomy showed
features of hypocalcemia on 2-4 post-operative day, hence, they are supplemented with oral
calcium and vitamin D3.
All the cases were followed up for 6months, two cases had husky voice without
any change in vocal cord movements.
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DISCUSSION
The observations and results of the present study were compared with the
available previous similar studies.
MEAN AGE AT PRESENTATION:
AUTHORS MEAN AGE IN YEARS
Das DK (1999) 35
Talepoor M(2005) 38.6
Quari F. (2005) 36.7
REHMAN A.U.(2009)* 34.7
Khurshid Anwar(2012)* 37
Present study 37.24
In the study done by Quari F and Talepoor M separately in 2005, reported the
mean age at presentation as 36.7years and 38.6years respectively. Khurshid Anwar
reported, in 2012, the mean age of presentation as 37years. From the present study, the
mean age at presentation found to be 37.27years, correlates with the previous studies.
Most of the earlier series reported peak incidence of solitary nodule thyroid in the
3rd and 4th decades. Bhansali S.K 5(1982), in his similar study , reported the peak
incidence in 4th and 5th decade. In the present study, the peak incidence found to be 3rd to
5th decades, which constitutes about 60% of the cases studied.
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SEX DISTRIBUTION:
AUTHOURS SEX INCIDENCE(M:F)
Dorairajan (1996) 1:9
Das DK(1999) 1:5.39
Gupta C(2001) 1:5
Present study 1:11.5
In the study done by Dorairajan(1996) and Das DK(1999) reported ratio of sex
incidence as 1:9 and 1:5.39 respectively. In the present study, its found to be 1:11.5,
which correlates with previous studies.
Because of periods of fluctuations in the demands of the hormonal requirement in
female in their life cycle(puberty, menstrual cycles, pregnancy, menopause), the chances
of thyroid nodule formation are very high as compared with male counterparts.
Distribution of non-neoplastic and neoplastic lesions diagnosed by FNAC:
AUTHOURS
NON-
NEOPLASTIC
NEOPLASTIC RATIO
Sarda AK(1997) 487 59 8.25:1
Das DK(1999) 346 85 4.07:1
Gupta C(2001) 470 30 15.66
Karur(2002) 32 15 2.13:1
Talepoor M(2005) 325 70 4.33:1
Hurtado Lopez 80 50 1.6:1
M(2005)
Nagada(2006) 51 18 2.83:1
Chao CT(2007) 276 264 1.04:1
Present study 36 14 2.57:1
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In the present study, neoplastic conditions include adenomas and all malignant
lesions. From the study, the ratio of non-neoplastic to neoplastic cases is about   2.57:1,
which is comparable to the studies done earlier like Karur(2002), Hurtado Lopez
M(2005), Nagada(2006), Chao CT(2007).
Distribution of malignancies by FNAC :
AUTHOURS PERCENTAGE
Sarda Ak et al(1997) 10.8
Karur K et al(2002) 18
Mundsad B et al(2006) 4.16
Present study 7.27
In the present study, among 4 cases of papillary CA, 3 were diagnosed with certainty
by FNAC and the rest one was suspicious of malignancy. But both the follicular CA were
initially reported as follicular neoplasm. From the study, distribution of malignancy is about
7.27, which is comparable with the earlier studies.
Aetiological incidence (in percentage):
Series MNG
ADENOMA
FOLLICULAR
CARCINOMA OTHERS
Total No.
Of cases
Zaman &
Bhagbati(1971) 83 9 8 - 2221
Ananth
Krishnan (1983) 12 47 2 2 104
Bhansali(1982) 71 20 9 - 449
Fenn(1980) 22 55 12 11 342
Kapur(1982) 28 50 11 11 221
Present series 36 22 12 30 50
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From the present study, commonest cause of solitary nodule is MNG, which is
comparable with the studies done by Fenn(1980) ,Kapur ( 1982) ,Bhansali(1982). The
common causes are follicular adnoma and adenomatous goitre.
Incidence of carcinoma:
STUDY YEAR PERCENTAGE
A S Fenn et al 1980 12.0%
Bhansali S K 1982 9.0%
Kapur et al 1982 11.0%
Wagana et al 2002 16%
Rehman A U 2009 11.4%
Present study 2015 12.0%
From the literature, the incidence of malignancy in thyroid nodule ranges from
5% to 30%. From the present study, the incidence found to be 12 %, which is comparable
with the study done by A S Fenn et al, Kapur et al, Rehman A U.
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CONCLUSIONS
The present study is a prospective analysis of 50 cases of solitary nodule of thyroid,
admitted in Thirunelveli medical college. Though a large number of patients are required to
come to better conclusions, based on the data and results obtained in the present study, the
following conclusions can be drawn:
- Solitary nodule of thyroid is more common in females.
- Solitary nodule of thyroid is more common the age group of 20-50years.
- Most of the patients with solitary nodule of thyroid present with swelling alone.
- Most of the patients with solitary nodule of thyroid are in euthyroid state and only few
present with toxicity and hypothyroidism.
- Incidence of malignancy in male patients presenting with solitary nodule thyroid is
more when compared to female patients presenting with the same.
- commonest cause of solitary nodule of thyroid is multi-nodular goitre.
- USG can be used to detect multi-nodular goitre in patients presenting with solitary
nodule thyroid.
- FNAC is the investigation of choice in the evaluation of solitary nodule of thyroid. It
has few pitfalls. In such situations, only histopathology can confirm the exact
pathology. It detects papillary carcinoma in a solitary nodule with high sensitivity and
specificity.
- Papillary carcinoma is the most common malignancy of thyroid, followed by follicular
carcinoma.
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SUMMARY
A prospective analysis of 50 cases of solitary nodule of thyroid, admitted inthirunelveli
medical college  has been made and summarized below:
- Commonest presentation of solitary nodule is swelling in front of neck.
- The peak age at presentation of solitary nodule thyroid is 3rd to 5th decade, constituting
about 60% of the cases.
- Solitary nodule is more common in females with the ratio M:F = 1:11.5.
- Most of the solitary nodule of thyroid are benign (88%).
- Most of patients with solitary nodule of thyroid are in euthyroid state(94%).
- After evaluation of solitary nodule thyroid,36% of all the clinically solitary nodule
turned out to be multi-nodular goitre.
- Common causes of solitary nodule thyroid are MNG (36%), follicular adenoma(22%)
and adenomatous goitre(24%).
- Incidence of malignancy of solitary nodule is about 12%. Male to female ratio in case of
malignant nodule is 1:5.
- Incidence of carcinoma in males presenting as thyroid nodule is higher (25%)
compared to that of females (10.87%).
- The most common malignancy in solitary nodule thyroid is papillary carcinoma (67%),
followed by follicular carcinoma(33%)
- FNAC is an important investigation in the evaluation of the solitary nodule of thyroid.
- Surgery has been the treatment of choice in most of the cases, either because of cosmetic
reasons or toxicity or FNAC diagnosis of follicular neoplasm or malignancy.
- Transient hypocalcemia is common after total thyroidectomy for malignancies.
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ANNEXURE-1
PROFORMA FOR CLINICAL STUDY OF SOLITARY NODULE OF
THYROID
Case No:
Name: Hospital:
Age: Unit:
Sex: D.O.A:
Occupation: D.O.D:
Address:
Contact No:
A. Clinical diagnosis:
B. Chief complaint and its duration:
a. Swelling
b. Pain
c. Others
C. History of presenting illness:
a. Swelling
i. Duration
ii. Site
iii. Mode of onset
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iv. Progress of the swelling
v. Presence of other swelling(s)
vi. Secondary changes
b. Pain
i. Duration
ii. Onset
iii. site
iv. Nature
v. Radiation
vi. Aggravating factors
vii. Relieving factors
c. Pressure symptoms
i. Dysphagia
ii. Dyspnea
iii. Hoarseness of voice
iv. Voice fatigue
d. Symptoms suggestive of BMR changes
i. Appetite: increased/decreased/good
ii. Weight:  increased/decreased/no significant change
iii. Sweating: increased/decreased/no significant change
iv. Any preference to hot or cold environment
102
e. Toxic symptoms
i. Primary toxicity
1. Irritability
2. Insomnia
3. Anxiety
4. Fear
5. Tremors of hands
6. Prominence of eyes
7. Diarrhea
8. Swelling of lower limbs- pretibial myxoedema
ii. Secondary toxicity
1. Palpitation
2. Precordial pain
3. Dyspnea on exertion
4. Swelling of lower limbs
f. Hypothyroid symptoms
i. Dullness
ii. Lethargy
iii. Loss of hairs
iv. Behavior-hypoactivity
v. Response to surroundings
g.  Menstrual history-menorrhagia/oligimenorrhoea/amenorrhoea
i. Flow
ii. Days
iii. Frequency
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h. Symptoms suggestive of malignancy
i. Rapid increase in size
ii. Presence of other swelling(s) in neck – lymph nodes
iii. Recent onset of pressure symptoms/change in voice
iv. Chest symptoms- cough/breathlessness/hemoptysis
v. Loss of weight and loss of appetite
D. Past history:
i. h/o any drug intake
ii. h/o irradiation to neck in childhood
iii. h/o diabetes/hypertension/tuberculosis/asthma/allergy
E. Family history
iv. h/o similar complaints in family members
v. h/o similar complaints in locality
F. Personal history
vi. Diet:
vii. Appetite:
viii. Sleep
ix. Bowel and bladder habits:
x. Habits:
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GENERAL PHYSICAL EXAMINATION
Appearance: Pallor:
Look:  Anxious/dull/normal Icterus:
Built: thin/moderate/obese Cyanosis:
Skin: Clubbing:
Hands: warm/moist/cold Lymphadenopathy:
Nutrition:
Tremors:
Vitals: pulse – rate:
- rhythm:
- volume:
- character:
Respiratory rate:
Temperature:
BP.:
LOCAL EXAMINATION
1. Inspection
Swelling(s) - number:
- shape:
- size:
- borders:
- extent:
- surface:
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- skin over the swelling:
- secondary changes: fungation/ulceration/inflammation -pulsation:
- engorged
veins: - trachea:
- any other swelling(s)-lymph nodes
2. Palpation:
-Local rise of temperature: -Tenderness:
- Number:
- Shape:
- Size:
- Site:
- Extent:
- Borders
- Surface:
- Consistency:
- Mobility -skin fixity
- on contraction of muscle
- anatomical plane
- Position of trachea:
- Carotids: normal/Displaced/Absent -Bruit:
- Dilated veins: -Regional lymph nodes:
3. Percussion:
- over sternum: Dull/Resonant
4. Auscultation:
- Tracheal position -Bruit
5. Measurement of neck at the most prominent part:
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SYSTEMIC EXAMINATION
Signs of toxicity-Primary
-Secondary
1. Cardiovascular system:
2. Respiratory system:
3. Central nervous system:
4. Per-abdominal examination:
CLINICAL DIAGNOSIS:
INVESTIGATIONS:
ROUTINE:
HB%: Total Count:
Differential Count: ESR:
Bleeding Time: Clotting Time:
Urine Routine: Albumin- ECG:
Sugar & microscopy-
Random Blood Sugar: Blood Urea:
Serum Creatinine: Chest-X-Ray:
HIV -1&2: HBsAg:
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SPECIFIC INVESTIGATIONS:
- FNAC of nodule:
- Thyroid Profile:
- Indirect Laryngoscopy:
- Plain X-Ray Neck:
- USG Neck:
TREATMENT:
Pre-operative:
Surgical:
- Operative Findings:
Post-operative:
HISTO-PATHOLOGICAL EXAMINATION: - Macroscopic:
- Microscopic:
FOLLOW-UP:
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ANNEXURE-2
CONSENT FORM
I/We ____________________age_________Hosp. No. ___________Ward
______________________, in my/our full senses hereby give my/our complete consent for
__________________ or any other procedure deemed fit which is a diagnostic / therapeutic
procedure / biopsy / transfusion / operation to be performed on me / my son / daughter
under any anesthesia deemed fit. The nature and risks involved in the procedure have been
explained to me in my own language to my satisfaction. For academic and scientific
purpose, the operation/ procedure may be recorded or photographed, or used for statistical
measurements.
Signature/thumb impression
Of the patient/guardian
Date:
Place:
Guardian:
Relationship:
Full address
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MASTER CHART
110
111
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KEY TO MASTER CHART
AG Adenomatous goiter
B Benign
CA Carcinoma
CG Colloid goiter
FA Follicular adenoma
FC Follicular carcinoma
FN Follicular neoplasm
HT Hemithyroidectomy
L Left
MNG Multinodular goiter
NCG Nodular colloid goitre
NTT Near total thyroidectomy
PC Papillary carcinoma
R Right
SC Simple cyst of thyroid
SNT Solitary nodule thyroid
STT Sub total thyroidectomy
TT Total thyroidectomy
